2015 Annual Meeting | Poster Session 05

Date Wednesday 04/22/15

Time 02:00 PM - 06:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation

CME Available No CME available

Event Timeline
02:00 PM - 06:30 PM	Abstract	001 - Differentiating the Logopenic and Nonfluent/Agrammatic Variants of Primary Progressive Aphasia by Selective Word Comprehension Impairment Collin H. York
02:00 PM - 06:30 PM	Abstract	002 - Cumulative, Additive Benefits of Memantine-Donepezil Combination Over Component Monotherapies in Moderate to Severe Alzheimer’s Dementia: A Pooled Area Under The Curve Analysis Alireza Atri, MD, PhD
02:00 PM - 06:30 PM	Abstract	003 - The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol: Known Kindreds and Preliminary Data Bradley F. Boeve, MD, FAAN
02:00 PM - 06:30 PM	Abstract	004 - Pseudo-Continuous Arterial Spin Labeling is Sensitive to Changes in Cerebral Blood Flow in Semantic Variant Primary Progressive Aphasia and Non-fluent/Agrammatic Primary Progressive Aphasia Christopher Olm
02:00 PM - 06:30 PM	Abstract	005 - Initial Experience with [18F]AV1451 PET in AD and non-AD Tauopathies Gil D. Rabinovici, MD, FAAN
02:00 PM - 06:30 PM	Abstract	006 - Clinical correlates and baseline predictors of progressive brain atrophy in progressive supranuclear palsy: results from the AL-108-231 davunetide trial Richard M. Tsai, MD
02:00 PM - 06:30 PM	Abstract	008 - Occupational Attainment Delays Cognitive Decline in Frontotemporal Degeneration
02:00 PM - 06:30 PM	Abstract	009 - Defining the white matter hyperintensity penumbra: a pulsed arterial spin labeling study
02:00 PM - 06:30 PM	Abstract	010 - Sensitivity and Specificity of New Criteria for the Diagnosis of Corticobasal Degeneration Clara Boyd, MD
02:00 PM - 06:30 PM	Abstract	011 - Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer’s disease
02:00 PM - 06:30 PM	Abstract	012 - Quantitative digital image analysis of Pick’s disease neuropatholgy David Irwin, MD
02:00 PM - 06:30 PM	Abstract	013 - GRN-related Frontotemporal Lobar Degeneration TDP43 Type A presenting as a case of Posterior Cortical Atrophy Sara B. Mitchell, MD
02:00 PM - 06:30 PM	Abstract	015 - Mitochondrial Encephalopathy with Lactic Acidosis and Stroke (MELAS) presenting as an apparent neoplastic process Aaron Rothstein, MD
02:00 PM - 06:30 PM	Abstract	016 - Concordance Between 11C-PIB-PET and AB42 In A Memory Clinic Patricio Chrem Mendez, MD
02:00 PM - 06:30 PM	Abstract	017 - Differential Progression of White Matter Hyperintensities in Early-Onset compared to Late-Onset Alzheimer’s Disease: a Longitudinal MRI Study Nicodemus E. Oey
02:00 PM - 06:30 PM	Abstract	018 - Decline in naming in patients with Primary Progressive Aphasia is associated with the strength of functional correlation between homologous Pre-Frontal cortices in the initial MRI
02:00 PM - 06:30 PM	Abstract	019 - Verbal episodic memory and spatial memory correlate differentially with hippocampal volume in older adults. Ali Ezzati, MD
02:00 PM - 06:30 PM	Abstract	020 - Description of a method: Assessment of phosphorylated Tau protein by immunohistochemistry in the skin of patients with neurodegenerative diseases Juan Carrizales-Rodriguez, Sr.
02:00 PM - 06:30 PM	Abstract	021 - Fibrillar Amyloid: Thinking Globally, Not Acting Locally
02:00 PM - 06:30 PM	Abstract	022 - Cross validation of imaging and CSF biomarkers in a clinical setting Daniela Perani, MD
02:00 PM - 06:30 PM	Abstract	023 - Presence of Cerebral Amyloid Modulates Phenotype and Pattern of Neurodegeneration in early Parkinson’s Disease Corey McMillan, PhD
02:00 PM - 06:30 PM	Abstract	024 - The Effects of asymptomatic B-amyloid positivity on Cerebral Metabolism and CSF-pTau levels Monica K. Gentchev
02:00 PM - 06:30 PM	Abstract	025 - Neuroticism Increases with Age in Cognitively Normal Older Adults who are PiB-Positive Carolyn Fredericks, MD
02:00 PM - 06:30 PM	Abstract	026 - Quantitative α-synuclein Level is associated with Higher Diffuse Amyloid Plaque and Amyloid Oligomer Burdens Ho-Yann Jong, MD
02:00 PM - 06:30 PM	Abstract	027 - Role of plasma clusterin in Mild cognitive impairment, Alzheimer’s disease and Vascular dementia Venugopalan Y. Vishnu, MD
02:00 PM - 06:30 PM	Abstract	028 - Investigating blood gene expression levels as a biomarker for LOAD. Mariet Allen, PhD
02:00 PM - 06:30 PM	Abstract	029 - Tau protein concentrations are significantly increased in CSF extracellular vesicles of patients with mild cognitive impairment due to Alzheimer’s disease Innocenzo Rainero, MD, PhD
02:00 PM - 06:30 PM	Abstract	030 - Increased Cerebrospinal Fluid Total-Tau Levels in Hereditary Behavioral-Variant Frontotemporal Dementia David Irwin, MD
02:00 PM - 06:30 PM	Abstract	031 - Hemoglobin is a potential risk factor for cognitive dysfunction in adults with sickle cell disease. Dana R. Jorgensen
02:00 PM - 06:30 PM	Abstract	032 - Early Development of Proliferative Retinopathy Increases Risk of Cognitive Dysfunction in Middle-Aged Adults with Type 1 Diabetes Karen Nunley
02:00 PM - 06:30 PM	Abstract	033 - Early Clinical Features of Familial and Sporadic Frontotemporal Dementia in an Italian FTD Cohort - The Apulia FTD Population-Based Registry Rosa Capozzo
02:00 PM - 06:30 PM	Abstract	034 - Incidence and Predictors of Poststroke Depression: Results from the Framingham Heart Study Joel Salinas, MD, MBA, MSc, FAAN
02:00 PM - 06:30 PM	Abstract	035 - Demographics and Impact on Diagnosis of Neurological Consultations in the ICU Natalie R. Weathered, MD, FAAN
02:00 PM - 06:30 PM	Abstract	036 - Healthcare Utilization after a Diagnosis of Conversion Disorder Alexander Merkler, MD
02:00 PM - 06:30 PM	Abstract	037 - Insights into the Classification of Myasthenia Gravis. Tetsuya Akaishi
02:00 PM - 06:30 PM	Abstract	038 - Breadth vs. Volume: The Outpatient Neurology Clinic Experience in Medical ��ɫ�� Dara V. Albert, DO, FAAN
02:00 PM - 06:30 PM	Abstract	039 - Perception of the Family Burden of Chronic Migraine: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study Dawn C. Buse, PhD
02:00 PM - 06:30 PM	Abstract	040 - Effects of Demographic and Socioeconomic Characteristics on Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study David W. Dodick, MD, FAAN
02:00 PM - 06:30 PM	Abstract	041 - Prevalence of Migraine Headache and its Weight on Neurological Burden in Africa: A 43-year Systematic Review and Meta-analysis of Community-based Studies. Yohannes W. Woldeamanuel, MD
02:00 PM - 06:30 PM	Abstract	042 - Pain Comorbidities of Episodic and Chronic Migraine: Results from the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study Ann Scher, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	043 - HIV Associated Neurocognitive Disorders (HAND) in Nigeria: Clinical Rating versus Global Deficit Score Methods
02:00 PM - 06:30 PM	Abstract	044 - Adult Tuberculous Meningitis in Qatar: A Descriptive Retrospective Study From Its Referral Center Yahia Z. Imam, MD, FAAN
02:00 PM - 06:30 PM	Abstract	045 - Etiologies of New Onset Seizure in HIV-infected Zambian Adults Omar Siddiqi, MD
02:00 PM - 06:30 PM	Abstract	046 - Predictors of Poor Outcome in Bacterial Meningitis: Retrospective Analysis of Nationwide Inpatient Sample Devanshi Dharaiya, MD
02:00 PM - 06:30 PM	Abstract	047 - Pilot Study of a Neuroepidemiologic Screening Tool in Rural Uganda Deanna Saylor, MD, MHS, FAAN
02:00 PM - 06:30 PM	Abstract	048 - Cluster of Acute Flaccid Paralysis and Cranial Nerve Dysfunction in Children Temporally Associated with an Enterovirus D68 Outbreak in Colorado Teri Schreiner, MD, MPH, FAAN
02:00 PM - 06:30 PM	Abstract	049 - Prevalence and Comorbid Factors Associated with Distal Symmetric Polyneuropathies in HIV+ and HIV- Adults in Urban and Rural Zambia Michelle P. Kvalsund, DO
02:00 PM - 06:30 PM	Abstract	050 - Mortality Predictors in Bacterial Meningitis Patients who developed Hydrocephalus Khadija Irshad, MD
02:00 PM - 06:30 PM	Abstract	051 - Progression to Clinically Meaningful Changes in ALSFRS-R Bulbar and Fine Motor Domains is Faster in Bulbar Onset and in Limb Onset Amyotrophic Lateral Sclerosis Patients Respectively Elena Ratti, MD
02:00 PM - 06:30 PM	Abstract	052 - Skeletal muscle, cardiac, and pulmonary imaging biomarkers of disease activity in a trial of exon-skipping for boys with Duchenne muscular dystrophy Ami K. Mankodi, MD, FAAN
02:00 PM - 06:30 PM	Abstract	054 - Search for Potential Biomarkers at Baseline in a Large ALS Cohort Study (ALS COSMOS): Plasma Creatinine and Urinary 8-oxo-deoxyguanosine. Hiroshi Mitsumoto, MD, FAAN
02:00 PM - 06:30 PM	Abstract	055 - A Promising Marker to Detect Chronic Pain Syndrome Elizabeth A. Strong, MD
02:00 PM - 06:30 PM	Abstract	056 - The Neuromuscular Features of Light Chain Deposition Disease Ling Zhang, MD
02:00 PM - 06:30 PM	Abstract	057 - GDF15 (Growth Differentiation Factor 15) Is the New Biomarker for Muscle-Related Mitochondrial Diseases Yasutoshi Koga, MD, PhD
02:00 PM - 06:30 PM	Abstract	058 - Initial Results from the NeuroNEXT SMA Infant Biomarker Study Stephen J. Kolb, MD, PhD
02:00 PM - 06:30 PM	Abstract	059 - Myotonic Discharges in Autophagic Vacuolar Myopathies: a Potentially Useful Marker Ludwig Gutmann, MD, FAAN
02:00 PM - 06:30 PM	Abstract	060 - A promissing method of CTS investigation: Median-radial nerve action potential splitting (MRS) Pablo B. Winckler, MD, PhD
02:00 PM - 06:30 PM	Abstract	062 - Atypical presentation of sporadic inclusion body myositis. Sheetal Shroff, MD
02:00 PM - 06:30 PM	Abstract	064 - Mononeuropathy multiplex associated with hemophagocytic lymphohistiocytosis mimicking vasculitis Chad Hoyle, MD
02:00 PM - 06:30 PM	Abstract	065 - Clinicopathological features of patients with neuromuscular disease showing CD8-MHC-1 complex pathology Chiseko Ikenaga, MD, PhD
02:00 PM - 06:30 PM	Abstract	066 - Clinical Significance of Cation Channel Antibodies in Motor Neuron Disease Rachel M. Donaldson, DO
02:00 PM - 06:30 PM	Abstract	067 - Clinical and molecular genetics spectrum of Thymidine Kinase 2 deficiency Caterina Garone
02:00 PM - 06:30 PM	Abstract	068 - Guillain Barre Syndrome: Predictors of Requirement of Mechanical Ventilation Devanshi Dharaiya, MD
02:00 PM - 06:30 PM	Abstract	069 - Pain Characteristics do not Distinguish Fibromyalgia Patients with Abnormal Skin Biopsy Victoria Lawson, MD, FAAN
02:00 PM - 06:30 PM	Abstract	070 - Diffusion Tensor Imaging (DTI) of the Cervical Cord in Sensory Neuronopathies Jean Levi Ribeiro De Paiva
02:00 PM - 06:30 PM	Abstract	071 - Hearing loss in Charcot-Marie-Tooth (CMT) disease Tiffany K. Grider, MS, CGC
02:00 PM - 06:30 PM	Abstract	072 - Characterization of Pain in Patients with Charcot-Marie-Tooth Diseases Derek C. Huang, MD
02:00 PM - 06:30 PM	Abstract	073 - Phenotypic spectrum and management of 25 patients ATTR Val122Ile Hayet Salhi
02:00 PM - 06:30 PM	Abstract	074 - Genotypic Evaluation of Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Study of the PMP22 Gene Duplication/Delection.
02:00 PM - 06:30 PM	Abstract	076 - Hypertensive neuropathy in phrenic nerve: an experimental study. Valeria Paula Fazan, MD, PhD
02:00 PM - 06:30 PM	Abstract	077 - Increased plasma level of pigment epithelium-derived factor is associated with diabetic neuropathy. Delaram Safarpour, MD, MSCE, FAAN
02:00 PM - 06:30 PM	Abstract	078 - Magnetic Resonance Neurography in the Diagnosis of Noncompressive Lumbosacral Radiculoplexus Neuropathies Nathaniel M. Robbins, MD
02:00 PM - 06:30 PM	Abstract	079 - Prognostic factors of status epilepticus in adults: a 6- year retrospective study Hoi Ki, Kate Lui, MD
02:00 PM - 06:30 PM	Abstract	080 - Cefepime- induced Nonconvulsive Status Epilepticus (NCSE), associated with Posterior Reversible Encephalopathy Syndrome (PRES): a Case Report. Emiliya Melkumova, MD
02:00 PM - 06:30 PM	Abstract	081 - Takotsubo Cardiomyopathy Due To Status Epilepticus - An Underreported and Lethal Sequela Imad R. Khan, MD
02:00 PM - 06:30 PM	Abstract	082 - Status Epilepticus Secondary to Hyperammonemia Manan Shah, MD, MBBS
02:00 PM - 06:30 PM	Abstract	083 - Good Outcome despite Early Refractory Myoclonic Status Epilepticus after Cardiopulmonary Arrest: A Case Report Alexandra S. Reynolds, MD
02:00 PM - 06:30 PM	Abstract	084 - Refractory Status Epilepticus Secondary to Atypical Rasmussen Encephalitis Successfully Managed With Aggressive Immunotherapy Sung-Min Cho, DO
02:00 PM - 06:30 PM	Abstract	085 - Clobazam as Add-on Therapy in Refractory Status Epilepticus Sanjeev Sivakumar, MD
02:00 PM - 06:30 PM	Abstract	086 - Primary Hyperammonemic Encephalopathy as a Mimicker of Non-convulsive Status Epilepticus: Therapeutic Implications of Underlying Etiology. Nandhagopal Ramachandiran, MBBS, DM, FRCP, FANA, FAAN
02:00 PM - 06:30 PM	Abstract	087 - Mortality, causes and predictors of death in status epilepticus Yoojin Lee, MD
02:00 PM - 06:30 PM	Abstract	088 - Does status epilepticus per se cause cerebrospinal fluid pleocytosis in the absence of infection? Farzad Moien Afshari, MD
02:00 PM - 06:30 PM	Abstract	089 - Comparison of Clinical and Neuropsychiatric profiles of patients with intermittent PNES (iPNES) and non-epileptic psychogenic status (NEPS) Kanika Arora, MD
02:00 PM - 06:30 PM	Abstract	090 - Assessment of Subjective Seizure Symptoms in Psychogenic Non-Epileptic Seizures: The Revised Psychosensory-Psychomotor Phenomena Interview (PPPI-PNES) Sana Sharrack
02:00 PM - 06:30 PM	Abstract	092 - Clinical and Neuropsychiatric profiles of patients with Psychogenic Non-epileptic Seizures (PNES) and Epilepsy Kanika Arora, MD
02:00 PM - 06:30 PM	Abstract	093 - Comparison of Characteristics of Patients with Non-epileptic versus Epileptic Seizures in Epilepsy Monitoring Unit Aradia Fu, MD
02:00 PM - 06:30 PM	Abstract	094 - Public Awarness, Knowledge And Attitude Toward Epilepsy In Aseer Region, Saudi Arabia Community Based Cross Sectional Study Adel Alhazzani, MD, FRCPC, FAAN
02:00 PM - 06:30 PM	Abstract	095 - The Relationship Between Level Of ��ɫ�� And Public Awarness, And Attitude Toward Epilepsy - Community Based Cross Sectional Study From Aseer Region, Saudi Arabia Ali M. Alqahtani
02:00 PM - 06:30 PM	Abstract	096 - Changes in Serum Osmolality are Associated with Brain Volume Change in Severe Hepatic Encephalopathy. Eric Liotta, MD
02:00 PM - 06:30 PM	Abstract	097 - Autoimmune Encephalitis: Are Immunomodulatory Therapies Effective? A Retrospective Review of Functional Ratings Prior to and Post Treatment Naveen George, DO
02:00 PM - 06:30 PM	Abstract	098 - Severe Global Cerebral Edema Secondary to Hypercapnic Respiratory Acidosis Responsive to Hyperosmolar Therapy: A Case Report David J. Roh, MD
02:00 PM - 06:30 PM	Abstract	099 - Recurrent Encephalopathy and Seizures as a Manifestation of Ibuprofen Meningoencephalitis Anik Amin, MD
02:00 PM - 06:30 PM	Abstract	100 - Recurrent Encephalitis after Seasonal Influenza Vaccine Priya Narwal, MD
02:00 PM - 06:30 PM	Abstract	101 - Mild Encephalopathy With Reversible Splenial Lesion Related to Antiepileptic Drugs: Report of 3 Cases Suraj Rajan, MD
02:00 PM - 06:30 PM	Abstract	103 - Fatal Cerebral Edema After Trazodone Overdose J. David Avila, MD, FAAN
02:00 PM - 06:30 PM	Abstract	104 - Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) with stroke like symptoms. A case report. Vijayakumar Javalkar, MD, MCh, FAAN
02:00 PM - 06:30 PM	Abstract	105 - Catatonia in Limbic Encephalitis Treated with Electroconvulsive Therapy Karin Mente, MD
02:00 PM - 06:30 PM	Abstract	106 - Lateropulsion - The case of a flip flopper Amy Chan, MD
02:00 PM - 06:30 PM	Abstract	107 - Occurrence of Post-Lumbar Puncture Headache in an Academic LP Clinic Brian Mac Grory, MB BCh BAO
02:00 PM - 06:30 PM	Abstract	108 - Nonparaneoplastic Autoimmune Dementia: Cognitive Profiles And Predictors Of Immunotherapy Response In A Latin American Cohort Galeno Rojas, MD
02:00 PM - 06:30 PM	Abstract	109 - Cannabinomimetic neurotoxicity Divya B. Mella, MD
02:00 PM - 06:30 PM	Abstract	110 - Disulfiram toxicity presenting with peripheral neuropathy and unique lesions on MRI brain. Nazely Ashikian, MD
02:00 PM - 06:30 PM	Abstract	111 - Inflammatory Radiculomyelopathy Associated with SAPHO Syndrome
02:00 PM - 06:30 PM	Abstract	112 - Diagnostic Criteria Of Chronic Inflammatory Demyelinatig Polyneuropathy In Diabetes Mellitus Itay Lotan, MD
02:00 PM - 06:30 PM	Abstract	113 - Unusual Cause of Severe Back Pain in a Patient with Isolated IgG Deficiency Awss Zidan, MD
02:00 PM - 06:30 PM	Abstract	114 - Interferon-alpha in a patient with West Nile Virus myelitis: A case-report. Rouzbeh Fateh, MD
02:00 PM - 06:30 PM	Abstract	115 - Intraventricular tobramycin for bacterial meningitis Na Tosha N. Gatson, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	116 - Transient Global Amnesia Syndrome: Report of patients evaluated in the first 24 hours Marcela Uribe Roca
02:00 PM - 06:30 PM	Abstract	117 - Clinical and Radiological Evolution in a Patient With Extrapontine Myelinolysis David P. Roeltgen, MD, FAAN
02:00 PM - 06:30 PM	Abstract	118 - SLIPPERS: Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Case Report Cynthia E. Armand, MD, FAAN
02:00 PM - 06:30 PM	Abstract	119 - Severe Necrotizing Myelopathy from Toxacariasis Rick Magun, MD
02:00 PM - 06:30 PM	Abstract	120 - FibroCartilaginous Embolism, an Underdiagnosed Cause of Spinal Cord Infarction; Critical Review of Literature, New Diagnostic Criteria, Mechanisms Mahmoud A. AbdelRazek, MD
02:00 PM - 06:30 PM	Abstract	121 - Unusual Extensive Collateral Venous Network in a Patient with Multiple Cerebral Venous Thromboses Sara H. Duffus
02:00 PM - 06:30 PM	Abstract	124 - Alice in Wonderland Syndrome Associated With a Temporo-Parietal Cavernoma Jeffrey M. Kornitzer, MD, FAAN
02:00 PM - 06:30 PM	Abstract	125 - Cerebral Fat Embolism Syndrome an Uncommon Form of Coma Ayman A. Al-Salaimeh, MD
02:00 PM - 06:30 PM	Abstract	126 - Acute Cerebral Infarction as the Presenting Feature of anti-PL-7 Anti-Synthetase Syndrome Nuala McNicholas, MBBS
02:00 PM - 06:30 PM	Abstract	127 - Major Hemorrhagic Complications are Associated with Lower Coated-Platelet Levels in Patients with Non-Lacunar Brain Infarction Calin I. Prodan, MD
02:00 PM - 06:30 PM	Abstract	128 - Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke
02:00 PM - 06:30 PM	Abstract	129 - Activated Protein C exert its Anti-apoptotic Activity mediates via PARP Inhibition Against Oxygen-Glucose Deprivation in Cultured Neuronal Cells Mukesh K. Sriwastva
02:00 PM - 06:30 PM	Abstract	130 - Factor VIII Level is Not Modifiable by Improved Glycemic Control in Patients with Ischemic Stroke Alyana Samai
02:00 PM - 06:30 PM	Abstract	131 - Stroke Impairs Bactericidal Function in Phagocytes Alexander Dressel, MD
02:00 PM - 06:30 PM	Abstract	132 - Serum Activity of Angiotensin Converting Enzyme 2, a Potential Stroke Biomarker, is Decreased in the Acute Phase of Rat and Human Ischemic Stroke Doug Bennion
02:00 PM - 06:30 PM	Abstract	133 - Troponin T Serum Level Is Not Associated with the Location and Volume of Acute Brain Infarction Michal Kral
02:00 PM - 06:30 PM	Abstract	134 - To determine the impact of serum albumin levels on admission with the outcomes in patients receiving IV-t-PA (alteplase) for treatment of acute ischemic stroke. Kaustubh S. Limaye, MD
02:00 PM - 06:30 PM	Abstract	135 - High-Sensitivity C-Reactive Protein, Erythrocyte Sedimentation Rate and Lactic Acid Are Associated With Internal Carotid Artery Occlusion in Chinese Stroke Patients Yongbo Zhang, MD, PhD
02:00 PM - 06:30 PM	Abstract	136 - A Systematic Review of Informed Consent in Acute Stroke Trials William B. Feldman
02:00 PM - 06:30 PM	Abstract	137 - Probabilistic model to predict the effect size of acute stroke trials Kasra Khatibi, MD
02:00 PM - 06:30 PM	Abstract	138 - Itemized NIHSS subsets predict positive MRI strokes in patients with mild deficits Shadi Yaghi, MD
02:00 PM - 06:30 PM	Abstract	139 - REDCap UVA Vascular Neurology Database Shareena A. Rahman, MD
02:00 PM - 06:30 PM	Abstract	140 - Interrater Reliability of the National Institutes of Health Stroke Scale: Rating by Emergency Room Physicians and Neurologists in a Population-Based Study Brian S. Katz, MD
02:00 PM - 06:30 PM	Abstract	141 - Is YouTube and Stroke a Bad Liaison?
02:00 PM - 06:30 PM	Abstract	142 - Two-Year Adherence To A Stroke Prevention Program In A Latin American Cohort
02:00 PM - 06:30 PM	Abstract	144 - Evaluating the Clopidogrel-Proton Pump Inhibitor Interaction by Comparing Platelet Aggregation to ADP with Clopidogrel in the Presence of Proton Pump Inhibitors Francis M. Gengo, PharmD
02:00 PM - 06:30 PM	Abstract	145 - Five year results of a stroke care network in Appalachia Michael Dobbs, MD
02:00 PM - 06:30 PM	Abstract	146 - Quality of In-Hospital Stroke Care in Veterans Affairs Hospitals Michael J. Lyerly, MD, FAAN
02:00 PM - 06:30 PM	Abstract	147 - Effectiveness Of A Structured Teaching Programme In Improving The Knowledge And Skills Of The Care Givers And Preventing Secondary Complications In Hospitalized Stroke Patients Rohit Bhatia, MD, MBBS, DM
02:00 PM - 06:30 PM	Abstract	148 - Health Coaching for Secondary Prevention in TIA Clinic Waimei A. Tai, MD, FAAN
02:00 PM - 06:30 PM	Abstract	149 - The Presence of an Advanced Practice Nurse Stroke Program Coordinator Decreases Door-to-Needle Times Michelle Whaley
02:00 PM - 06:30 PM	Abstract	150 - Assessment of hospital readmissions in stroke patient population from the Stroke Center at the University of Kentucky: as a quality measure Abdullah Al Sawaf, MD
02:00 PM - 06:30 PM	Abstract	151 - Analysis of 30 Day Unexpected Readmission Rates in Stroke Patients at an Academic Acute-care Hospital David S. Kushner, MD, FAAN
02:00 PM - 06:30 PM	Abstract	152 - Improving Resident Performance in Acute Stroke Management Through Simulation Based Training Jami H. Johnsen, MD
02:00 PM - 06:30 PM	Abstract	153 - Does hospitalist directed care reduce the length of stay for acute ischemic stroke patients and improve adherence to the “Get with the Guidelines” inpatient quality measures? Wondwossen G. Tekle, MD
02:00 PM - 06:30 PM	Abstract	154 - Timing of Follow-up After Acute Ischemic Stroke And Readmissions A. Blake Buletko, MD
02:00 PM - 06:30 PM	Abstract	155 - Acute and Long-term Management of Symptomatic Internal Carotid Artery Dissection in the Setting of Newly Diagnosed Cerebral Amyloid Angiopathy: To Anticoagulate, or Not to Anticoagulate? Ilan J. Danan, MD
02:00 PM - 06:30 PM	Abstract	156 - Pontine Infarct due to Isolated Basilar Artery Dissection causing Supranuclear Facial Palsy Shivam O. Mittal, MD, FAAN
02:00 PM - 06:30 PM	Abstract	157 - Intracranial Arterial Dissections Resulting From Increased Sympathetic Drive Prachi Mehndiratta, MD
02:00 PM - 06:30 PM	Abstract	158 - Systemic inflammatory markers in cerebral artery dissection
02:00 PM - 06:30 PM	Abstract	159 - Intraarterial Thrombolysis And Endovascular Treatment is Safe and Effective In Patients With Ischemic Stroke Due To Dissection Judd M. Jensen, MD
02:00 PM - 06:30 PM	Abstract	160 - Outcome of Acute Ischemic Stroke Caused by Cervicocephalic Arterial Dissection Following Intravenous Thrombolysis and/or Endovascular Treatment. Ahmad S. Ghasan, MD
02:00 PM - 06:30 PM	Abstract	161 - Cervical Artery Dissections in the Vancouver General Hospital (VGH) Stroke Database: A common stroke mechanism? Laura Wilson, MD
02:00 PM - 06:30 PM	Abstract	162 - Carotid spot sign: an early marker of carotid artery injury Tirisham Gyang, MD
02:00 PM - 06:30 PM	Abstract	163 - The cerebellar participation in spontaneous post-stroke aphasia recovery: a longitudinal fMRI study Rodolphe Nenert
02:00 PM - 06:30 PM	Abstract	164 - Transcranial Magnetic Stimulation (TMS) as a tool for stroke motor recovery: What are we targeting? Muhammed Gunduz, MD
02:00 PM - 06:30 PM	Abstract	165 - Cortical Reorganization and Magnetoencephalographic Correlates for Paretic Hand Recovery after Stroke Chih-Wei Tang, MD
02:00 PM - 06:30 PM	Abstract	166 - White matter integrity predicts language deficits in chronic post-stroke aphasia Shihui Xing, MD, PhD
02:00 PM - 06:30 PM	Abstract	167 - Using a Delphi Panel to Identify a Treatment Paradigm for Injecting Botulinum Toxin to Treat Common Postures in Post-Stroke Upper Limb Spasticity David M. Simpson, MD, FAAN
02:00 PM - 06:30 PM	Abstract	168 - Monitoring Treatment Effects of Transcranial Magnetic and Direct Current Stimulation in Patients with Post-stroke Aphasia: A Meta-Analysis Study Priyanka P. Shah-Basak, PhD
02:00 PM - 06:30 PM	Abstract	170 - Uncontrolled Discharge Diastolic Blood Pressure is Associated with Favorable Outcome after Ischemic Stroke Konrad Schlick, MD, FAAN
02:00 PM - 06:30 PM	Abstract	172 - Cortical Deficits and Prior Stroke Predict Stroke Recurrence in Patients with Mild Deficits Shadi Yaghi, MD
02:00 PM - 06:30 PM	Abstract	173 - Memantine Treatment for Post-stroke Aphasia: A Case Control Study Jennie Valles, MD
02:00 PM - 06:30 PM	Abstract	174 - Preliminary Assessment of the Motor Activity Log-28 in Patients with Chronic Stroke Alexandra C. Simpson, MD
02:00 PM - 06:30 PM	Abstract	175 - Prism adaptation improves neglect-related motor perseveration Amit Chaudhari, MD, PhD
02:00 PM - 06:30 PM	Abstract	176 - Walking Quality During Inpatient Stroke Rehabilitation Assessed by Wireless Sensing Andrew K. Dorsch, MD
02:00 PM - 06:30 PM	Abstract	177 - Induction of Functional and Structural Plasticity by Intermittent Theta Burst Stimulation in Post-Stroke Aphasia Joseph C. Griffis
02:00 PM - 06:30 PM	Abstract	178 - Evaluation of a clinician worn device for the quantitative assessment of abnormal muscle tone type and severity
02:00 PM - 06:30 PM	Abstract	179 - Co-occurrence of spatial neglect and perseveration contributes to cognitive and functional impairment.
02:00 PM - 06:30 PM	Abstract	180 - Robot-Assisted Therapy Improves Motor Function in Individuals after Cerebral Hemispherectomy Susan Shaw, MD
02:00 PM - 06:30 PM	Abstract	181 - Medication Self-Administration after Stroke Mosunmola Oyawusi, MD
02:00 PM - 06:30 PM	Abstract	182 - What’s the difference between Rest and Rest? Defining Baseline Brain States Important for Cognition
02:00 PM - 06:30 PM	Abstract	183 - Arachnoiditis Mimicking an Intrathecal Catheter Tip Granuloma Pruthu P. Patel, MD
02:00 PM - 06:30 PM	Abstract	184 - Feasibility of Telerehabilitation in Patients with Significant Mobility Disability due to Multiple Sclerosis Joseph Finkelstein
02:00 PM - 06:30 PM	Abstract	185 - The Effect of Cooling on Community-Based Walking in Heat-Sensitive Patients with Multiple Sclerosis: Findings From the Use of Wireless Activity Monitoring Andrew K. Dorsch, MD
02:00 PM - 06:30 PM	Abstract	186 - Comparison of the Kurtkze Expanded Disability Status Scale and the Functional Independence Measure: Measures of Multiple Sclerosis Related Disability Meheroz H. Rabadi, MD, FAAN
02:00 PM - 06:30 PM	Abstract	187 - Identification and Management of Dynamic Cord Compression using Dynamic Magnetic Resonance Imaging Deepti Anbarasan, MD
02:00 PM - 06:30 PM	Abstract	188 - A Network-Based Cognitive Rehabilitation in patients with Multiple Sclerosis and Mild Cognitive Impairment
02:00 PM - 06:30 PM	Abstract	189 - Detection of Postural Sway Abnormalities by Wireless Inertial Sensors in Minimally Disabled Patients with Multiple Sclerosis Andrew Solomon, MD, FAAN
02:00 PM - 06:30 PM	Abstract	190 - Evaluation of the revised 2013 MS clinical course definitions in the CLIMB real world cohort Tanuja Chitnis, MD, FAAN
02:00 PM - 06:30 PM	Abstract	191 - No Evidence of Disease Activity - Past, Present, and Future Richard A. Rudick, MD, FAAN
02:00 PM - 06:30 PM	Abstract	192 - ‘Doctor, can I stop my medicine?’ Analysis of disease course after stopping disease-modifying therapy in stable MS patients Ilya Kister, MD, FAAN
02:00 PM - 06:30 PM	Abstract	193 - Are individuals with Radiologically Isolated Syndrome have a different clinical outcome once they convert to Clinically Isolated Syndrome? Aksel Siva, MD
02:00 PM - 06:30 PM	Abstract	194 - Cognition in MS across the Lifespan
02:00 PM - 06:30 PM	Abstract	195 - Isolated cognitive relapses and long-term cognitive decline in multiple sclerosis Matteo Pardini, MD, PhD
02:00 PM - 06:30 PM	Abstract	196 - German Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) Iris Katharina Penner, PhD
02:00 PM - 06:30 PM	Abstract	197 - Social cognition impairment according to the clinical phenotype of multiple sclerosis
02:00 PM - 06:30 PM	Abstract	198 - Depression and MRI Metrics in the CombiRx Trial Lael Stone, MD
02:00 PM - 06:30 PM	Abstract	199 - Marital Status and Functional Systems Scores in a Population-Based Multiple Sclerosis Cohort Jill Settle
02:00 PM - 06:30 PM	Abstract	200 - A Genders and Culture Comparison of Psychological and Social Aspects of Quality of Life in Multiple Sclerosis Patients Heidemarie Lex, PhD
02:00 PM - 06:30 PM	Abstract	201 - Validation Of The Brief International Cognitive Assessment For Multiple Sclerosis (BICAMS) in Argentina Sandra Vanotti, MD
02:00 PM - 06:30 PM	Abstract	202 - Adding brain volume loss to the modified Rio scoring system improves prediction of future disability progression: Analyses from fingolimod Phase III trials Maria Pia Sormani
02:00 PM - 06:30 PM	Abstract	203 - Monitoring Disease Progression in Aging Population with Multiple Sclerosis Vasu Saini, MD
02:00 PM - 06:30 PM	Abstract	204 - Loss of lower limb Motor Evoked Potentials (MEP) as a sign of Primary Progressive Multiple Sclerosis (PPMS) progression Rainer W. Paine, MD, PhD
02:00 PM - 06:30 PM	Abstract	205 - Prognostic Value Of Visual Evoked Potentials In Patients With Multiple Sclerosis Eva Costa Arpin, MD
02:00 PM - 06:30 PM	Abstract	206 - Pregnancy does not prevent degeneration of retinal axons in multiple sclerosis
02:00 PM - 06:30 PM	Abstract	207 - Multiple Sclerosis, Cognitive Profile and Cognitive Testing: Predictability of SDMT and Computerized Cognitive Testing in Differentiating Employment versus Unemployment in Patients with Multiple Sclerosis Mark Gudesblatt, MD
02:00 PM - 06:30 PM	Abstract	208 - Stress burden and satisfaction with treatment in caregivers and patients with Multiple Sclerosis. MS-Feeling Study
02:00 PM - 06:30 PM	Abstract	209 - Cytokine Profile in the Cerebrospinal Fluid of MS and CIDP Patients Arianna Sartori, MD
02:00 PM - 06:30 PM	Abstract	210 - Prostaglandin F2α Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Role in Multiple Sclerosis M. M. Paz Soldan, MD, PhD
02:00 PM - 06:30 PM	Abstract	211 - Evaluation of CSF and serum Fetuin-A, CSF S100B and GFAP as predictive markers in multiple sclerosis Ayse Altintas, MD
02:00 PM - 06:30 PM	Abstract	212 - Transglutaminase 6 is a potential biomarker of disease activity and astrocytic proliferation in MS. Daniel Gratch
02:00 PM - 06:30 PM	Abstract	213 - Cerebrospinal Fluid Haptoglobin (Hp) Levels are elevated in MS patients with progressive disease Bianca A. Ulloa
02:00 PM - 06:30 PM	Abstract	214 - Fetuin-A Correlates with Cortical Demyelination and is a CSF Biomarker of Disease Activity in Progressive MS Mark Landy
02:00 PM - 06:30 PM	Abstract	215 - Fetuin-A, a CSF Biomarker of MS Disease Activity, is Upregulated at the Blood Brain Barrier Langan Ruth-Anne
02:00 PM - 06:30 PM	Abstract	216 - Proteomic Analysis in CSF Identified Subtype Specific and Shared Molecular Pathways for Multiple Sclerosis Clinical Phenotypes
02:00 PM - 06:30 PM	Abstract	217 - CSF and serum levels of interleukin-6, interleukin-8, interleukin-10, beta-2-microglobulin and orosomucoid at the time of first clinical symptoms in MS patients Zuzana Matejcikova
02:00 PM - 06:30 PM	Abstract	218 - Cerebrospinal fluid Osteopontin and Neurofilament levels mark different patterns of brain atrophy in Clinically Isolated Syndrome
02:00 PM - 06:30 PM	Abstract	219 - Existence and significance of antibody against the inward rectifying potassium channel KIR4.1 in patients with multiple sclerosis in western part of Turkey Derya Kaya
02:00 PM - 06:30 PM	Abstract	220 - Clinical and Etiopathological Evaluation of the Patients with OCB IgG Pattern-IV and V Positivity
02:00 PM - 06:30 PM	Abstract	221 - Biomarkers and Relapse in CombiRx Hemant Tiwari
02:00 PM - 06:30 PM	Abstract	222 - Ocular Motor Biomarkers of Progressive Cerebral Dysfunction in Multiple Sclerosis
02:00 PM - 06:30 PM	Abstract	223 - Retinal neuronal and axonal loss over time as markers of disease progression and activity in Multiple Sclerosis: A pilot study Salim Chahin, MD
02:00 PM - 06:30 PM	Abstract	224 - Impairment of the Retinal Nerve Fiber Integrity and Blood Flow Velocity in Multiple Sclerosis Hong Jiang, MD, PhD
02:00 PM - 06:30 PM	Abstract	225 - Decreased Optic Nerve Head Blood Flow Index Highlights Abnormal Retinal Microcirculation in Multiple Sclerosis Rebecca Spain, MD, MSPH, FAAN
02:00 PM - 06:30 PM	Abstract	227 - Interleukine 17 is not detected in Active MS Patients' sera but in CSF in radiologically and clinically isolated syndromes Christine Lebrun Frenay, MD, FAAN
02:00 PM - 06:30 PM	Abstract	228 - The Relation between Meningeal Inflammation, Cortical Demyelination and White Matter Lesional Activity in Chronic Multiple Sclerosis: a Pilot Study Valeria Ramaglia
02:00 PM - 06:30 PM	Abstract	229 - Immune Regulatory Mechanisms involved in IL-27 induced Tolerogenic myeloid DCs Felipe Von Glehn Silva, MD, PhD, MSc, FAAN
02:00 PM - 06:30 PM	Abstract	230 - B1 Cells are Unaffected by Immune Modulatory Treatment in Remitting-Relapsing Multiple Sclerosis Patients Damiano M. Rovituso
02:00 PM - 06:30 PM	Abstract	231 - Th1 and Th17 cytokines profile and its relation to demographic, clinical and radiological features in early disease stage Multiple Sclerosis.
02:00 PM - 06:30 PM	Abstract	232 - Deep sequencing of T-cell receptor repertoire reveals enrichment of highly expanded clonotypes in cerebrospinal fluid from patients with multiple sclerosis Alessandra De Paula Alves Sousa
02:00 PM - 06:30 PM	Abstract	233 - Thermal Stable Immunoglobulin G Antibodies in Multiple Sclerosis Ian Stewart
02:00 PM - 06:30 PM	Abstract	234 - Myelin Oligodendrocyte Glycoprotein is the Primary Myelin Protein Target of CSF B-cell Antibodies in MS Pak Ho Au
02:00 PM - 06:30 PM	Abstract	235 - Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
02:00 PM - 06:30 PM	Abstract	236 - Humoral Response to Epstein-Barr virus is Associated with Cortical Pathology in Patients with Multiple Sclerosis Murali Ramanathan, PhD
02:00 PM - 06:30 PM	Abstract	237 - Excess Lipid Accumulation in Cortical Neurons in Multiple Sclerosis May Lead to Autophagic Dysfunction and Neurodegeneration
02:00 PM - 06:30 PM	Abstract	238 - Metabolite Profiling of Cerebrospinal Fluid Derived from MS Patients Danielle Blemur
02:00 PM - 06:30 PM	Abstract	239 - Functional Characterization of Myeloid Dendritic Cells in Peripheral Blood of Patients with Multiple Sclerosis
02:00 PM - 06:30 PM	Abstract	240 - Retinal Structure Injury and CSF Humoral Response in Multiple Sclerosis Jessica Chorostecki
02:00 PM - 06:30 PM	Abstract	241 - The role of chronic inflammation on amyloid burden in multiple sclerosis Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN
02:00 PM - 06:30 PM	Abstract	242 - Global metabolomics identifies perturbation of multiple metabolic pathways in Multiple Sclerosis Pavan Bhargava, MD, FAAN
02:00 PM - 06:30 PM	Abstract	243 - Estrogen receptor alpha in peripheral blood lymphocytes of multiple sclerosis patients: a pivotal study of its role in pregnant patients Marinella Clerico, MD
02:00 PM - 06:30 PM	Abstract	244 - Multiple Sclerosis and Epstein-Barr Virus: Antibodies to Nuclear Antigen 1 also Bind a Human Ribonucleoprotein John W. Lindsey, MD
02:00 PM - 06:30 PM	Abstract	245 - Blood-Brain Barrier Permeability and Brain Injury in CIS Patients Tomas Uher
02:00 PM - 06:30 PM	Abstract	246 - Does CSF Infrared Spectroscopy Useful in Diagnosing RRMS Patients During the First Clinical Attack? Levent Ocek
02:00 PM - 06:30 PM	Abstract	247 - What Does An Isolated Cerebrospinal Fluid Monoclonal Band Mean: A Tertiary Centre Experience
02:00 PM - 06:30 PM	Abstract	248 - Brain temperature is elevated in relapsing-remitting relative to progressive multiple sclerosis Victoria Leavitt, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	249 - New Acute Severity Scale for Neuromyelitis Optica Relapses Michael Levy, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	250 - Pregnancy outcome in aquaporin-4 positive neuromyelitis optica spectrum disorder
02:00 PM - 06:30 PM	Abstract	251 - Influence of Female Sex and Fertile Age on Neuromyelitis Optica (NMO) Nadja Borisow
02:00 PM - 06:30 PM	Abstract	252 - Immunological Analysis of MOG autoantibody positive NMOSD and aquaporin-4 autoantibody positive NMOSD Satoru Tanaka, MD
02:00 PM - 06:30 PM	Abstract	253 - NMO IgG:The Impact of the NMO Biomarker on Diagnosis and Treatment of NMO and NMOSD Luis F. Tornes, MD
02:00 PM - 06:30 PM	Abstract	254 - Processing Speed and Informant Reports of Executive Functioning in Neuromyelitis Optica Ana Arenivas, PhD
02:00 PM - 06:30 PM	Abstract	255 - Depressive State and Chronic Fatigue in Neuromyelitis Optica. Tetsuya Akaishi
02:00 PM - 06:30 PM	Abstract	256 - Cognitive Function and Fatigue in Patients with Neuromyelitis Optica: comparison with MS subtypes Cris S. Constantinescu, MD, PhD
02:00 PM - 06:30 PM	Abstract	257 - Bevacizumab is Safe in Acute Relapses of Neuromyelitis Optica Michael Levy, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	258 - Rituximab as First-Line Therapy in Neuromyelitis Optica: Efficiency and Tolerability
02:00 PM - 06:30 PM	Abstract	259 - Autologous Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica - An Update Jodie Burton, MD, FAAN
02:00 PM - 06:30 PM	Abstract	260 - Efficacy of Rituximab in refractory Neuromyelitis Optica Jerome De Seze
02:00 PM - 06:30 PM	Abstract	261 - Laquinimod prevents NMOIg-induced disease exacerbation in a model of neuromyelitis optica
02:00 PM - 06:30 PM	Abstract	262 - Efficacy and Safety of Tocilizumab as Second Line Therapy in Neuromyelitis Optica Unresponsive to Rituximab
02:00 PM - 06:30 PM	Abstract	263 - Dalfampridine for symptomatic treatment of neuromyelitis optica
02:00 PM - 06:30 PM	Abstract	264 - Safety of Rituximab as First-line Therapy in Neuromyelitis Optica (NMO) and NMO-spectrum Disorders: Five Years of Experience Emma Meyers, MD
02:00 PM - 06:30 PM	Abstract	265 - Prospective Evaluation of Maintenance Plasma Exchange (mPLEX) for Attack Prevention in Neuromyelitis Optica Spectrum Disorder: Preliminary Feasibility, Safety, and Efficacy Data Dean M. Wingerchuk, MD, FAAN
02:00 PM - 06:30 PM	Abstract	266 - Use of Tocilizumab in a Pediatric Patient with Aggressive Neuromyelitis Optica Spectrum Disorder Sona Narula, MD
02:00 PM - 06:30 PM	Abstract	267 - Diverse Spinal Cord Pathology in Neuromyelitis Optica Robert W. Charlson, MD
02:00 PM - 06:30 PM	Abstract	268 - Activation of plasmacytoid dendritic cells in neuromyelitis optica patients Rafael P. Dias-Carneiro, MD
02:00 PM - 06:30 PM	Abstract	269 - Aquaporin-4 antibody negative neuromyelitis optica with extensive hemispheric brain lesion: a pathological study Recai Turkoglu
02:00 PM - 06:30 PM	Abstract	270 - Neuromyelitis optica's related optic neuritis can be distinguished by optic nerve enhancement characteristics and resistance to steroids Dan S. Buch
02:00 PM - 06:30 PM	Abstract	271 - Serum chitinase 3-like 1 levels in patients with multiple sclerosis and neuromyelitis optica Derya Kaya
02:00 PM - 06:30 PM	Abstract	272 - The plasma antiaquaporin antibodies and the outcome of myelitis in neuromyelitis optica and neuromyelitis optica spectrum disorders: Any relationship? Egemen Idiman, MD
02:00 PM - 06:30 PM	Abstract	273 - Natural Course Of Neuromyelitis Optica(NMO) In Patients With No Long-Term Treatment Ayse Altintas, MD
02:00 PM - 06:30 PM	Abstract	274 - Recurrent Optic Neuritis (rON) is characterised by Anti-MOG Antibodies: A follow-up study Haralambos Alexopoulos
02:00 PM - 06:30 PM	Abstract	275 - Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients Mitchell Silver, MD
02:00 PM - 06:30 PM	Abstract	276 - Characterization of the Spectrum of Argentinean Neuromyelitis Optica according to the diagnostic criteria and AQP4 IgG serostatus Andres M. Villa, MD
02:00 PM - 06:30 PM	Abstract	277 - Tremor on Smiling. Deepak Kalra, MD, PhD, MPH
02:00 PM - 06:30 PM	Abstract	278 - Reduced Purkinje Cell Counts in Essential Tremor Cases vs. Controls: Further Support for the Neurodegenerative Hypothesis of Essential Tremor Elan D. Louis, MD, MS, FAAN
02:00 PM - 06:30 PM	Abstract	279 - Unilateral Focused Ultrasound Thalamotomy in Essential Tremor: 3 year safety and efficacy data Binit Shah, MD, FAAN
02:00 PM - 06:30 PM	Abstract	280 - Optimal Speech Outcome Requires Precise Stimulation Location in Deep Brain Stimulation for Essential Tremor Joseph Y. Matsumoto, MD
02:00 PM - 06:30 PM	Abstract	281 - Dexmedetomidine Affects an Essential Tremor During DBS Surgery Evgeny Tsimerinov, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	283 - Self-perception of tremor and dyskinesia Umer Akbar, MD
02:00 PM - 06:30 PM	Abstract	284 - Progressive Cerebellar Atrophy in Patients with Tremor-Predominant Parkinson’s Disease
02:00 PM - 06:30 PM	Abstract	285 - Deep Brain Stimulation (DBS) Improves Refractory Tremor Caused By Central Pontine Myelinolysis (CPM)
02:00 PM - 06:30 PM	Abstract	286 - Analysis of Parkinson's disease prodromal symptoms among Essential tremor subjects: Is Essential tremor a risk factor for the development of Parkinson's disease? Richard Salazar, MD, FAAN
02:00 PM - 06:30 PM	Abstract	287 - Predictive testing for Huntington’s disease (HD): Clinical characteristics and motivations of individuals at one academic center Andrew Herndon
02:00 PM - 06:30 PM	Abstract	288 - Using a Wii Balance Board to Measure Disease Onset in Huntington’s disease Andrew Herndon
02:00 PM - 06:30 PM	Abstract	289 - Phenotypic Variability in Huntington Disease: An Observational Prospective Study.
02:00 PM - 06:30 PM	Abstract	290 - Assessing psychiatric symptoms in individuals with, and at risk for, Huntington’s disease Jody Corey-Bloom, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	291 - Objective Measurement of Gait Abnormalities in Huntington Disease using a Shoe-Worn Inertial Sensor Penelope Hogarth, MD
02:00 PM - 06:30 PM	Abstract	292 - Time Processing in Huntington’s Disease Emilia M. Gatto, MD, FAAN
02:00 PM - 06:30 PM	Abstract	293 - Intermediate CAG repeats in Huntington´s disease. Analysis of the European Huntington´s Disease Cohort Network´s Registry. Esther Cubo Delgado, MD, PhD, FAAN
02:00 PM - 06:30 PM	Abstract	294 - Huntington’s disease and the heart: Electrocardiogram abnormalities suggest cardiac involvement Christopher D. Stephen, MB ChB, FRCP, MSc, SM
02:00 PM - 06:30 PM	Abstract	295 - Optical Coherence Tomography In Huntington Disease Patients. Emilia M. Gatto, MD, FAAN
02:00 PM - 06:30 PM	Abstract	296 - A Case of "Prodromal" Huntington's Disease with Neuropathology Daphne Robakis, MD
02:00 PM - 06:30 PM	Abstract	297 - Therapeutic Benefit Of A HTT-Lowering Antisense Oligonucleotide Targeting The CAG-Repeat In The R6/2 Huntington’s Disease Mouse Model
02:00 PM - 06:30 PM	Abstract	298 - Visualisation of Nerve Fibre Orientation in the Human Optic Chiasm Using Photomicrographic Image Analysis Christian J. Lueck, MD, FAAN
02:00 PM - 06:30 PM	Abstract	299 - Contrast Sensitivity Visual Acuity is Degraded in REM Sleep Behavior Disorder Jacqueline Sanchez
02:00 PM - 06:30 PM	Abstract	300 - Attenuated Hunter Syndrome: A Rare Cause of Simultaneous Retinal and Optic Nerve Disease Kannan M. Narayana, MD
02:00 PM - 06:30 PM	Abstract	301 - Acute Retinal Necrosis in the Setting of Varicella Zoster Vasculopathy - Case Report & Review of Literature Ali Saeed, MD
02:00 PM - 06:30 PM	Abstract	302 - Retinal Pathology in Idiopathic Moyamoya Angiopathy Detected by Optical Coherence Tomography Philipp Albrecht, PhD
02:00 PM - 06:30 PM	Abstract	304 - Obesity and Overweight are Highly Prevalent in Pediatric Secondary Pseudotumor Cerebri Syndrome Grace Paley, MD, PhD
02:00 PM - 06:30 PM	Abstract	305 - Association between sociodemographic factors and outpatient appointment adherence in patients with idiopathic intracranial hypertension Asha V. Shah
02:00 PM - 06:30 PM	Abstract	307 - Retinal Oximetry-Derived Biomarkers of Metabolic Dysfunction in MS Marlen Lucero
02:00 PM - 06:30 PM	Abstract	308 - Characterization of Idiopathic Intracranial Hypertension (IIH) in Qatar
02:00 PM - 06:30 PM	Abstract	309 - Asymmetry of the Vertical Translational Vestibulo-Ocular Reflex in Idiopathic Downbeat Nystagmus Mark F. Walker, MD
02:00 PM - 06:30 PM	Abstract	310 - Afferent and Efferent Visual System Involvement in Cerebrotendinous Xanthomatosis Francesca Rosini, MD
02:00 PM - 06:30 PM	Abstract	311 - Saccadic oscillations after doping suggest a possible mechanism for cerebellar and omnipause neurons dysfunction Elena Pretegiani
02:00 PM - 06:30 PM	Abstract	312 - Comparison of Cirrus and Spectralis Optical Coherence Tomography: Factors Associated With Differences in Retinal Nerve Fiber Thickness Measurement
02:00 PM - 06:30 PM	Abstract	313 - Clinical Features, Diagnostic Findings, and Treatment of Adult-Onset Opsoclonus-Myoclonus Syndrome: A Case Series Pooja S. Raibagkar, MD
02:00 PM - 06:30 PM	Abstract	314 - Retinal ganglion cell injury in early pediatric onset MS Jennifer Graves, MD, PhD
02:00 PM - 06:30 PM	Abstract	315 - Miller Fisher Syndrome from Asialo-GM1 Antibodies: “How can a Rare Disease Become Rarer?” Amanda D. Tomlinson
02:00 PM - 06:30 PM	Abstract	316 - Extraocular muscle fatigue evaluation in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
02:00 PM - 06:30 PM	Abstract	317 - Validation of strategies to streamline high and low contrast visual acuity testing in ALS subjects Lindsay Boven
02:00 PM - 06:30 PM	Abstract	318 - Coning Following Lumbar Puncture in a Patient With Idiopathic Intracranial Hypertension Christian J. Lueck, MD, FAAN
02:00 PM - 06:30 PM	Abstract	319 - Retinal lesion evolution in Susac syndrome Alexander U. Brandt, MD
02:00 PM - 06:30 PM	Abstract	320 - Comparative study between benign paroxysmal positional vertigo (BPPV) of the horizontal canal (H-BPPV) and posterior canal (P-BPPV).
02:00 PM - 06:30 PM	Abstract	321 - Burkitt’s Lymphoma presenting with Bilateral Abducens Palsy Ela M. Akay

Faculty Disclosures
Claudia F. Lucchinetti, MD, FAAN	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Salvatore DiMauro, MD	No disclosure on file
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Elaine Wyllie, MD	Dr. Wyllie has received publishing royalties from a publication relating to health care.
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Mindy A. Aisen, MD	No disclosure on file
Bruce H. Dobkin, MD, FAAN	No disclosure on file
Laura Lennihan, MD, FAAN	No disclosure on file
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Horacio C. Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Barbara S. Giesser, MD, FAAN	Dr. Giesser has received publishing royalties from a publication relating to health care. Dr. Giesser has a non-compensated relationship as a advisory committee member with National MS Society that is relevant to AAN interests or activities.
Grant Liu, MD, FAAN	Dr. Liu has received publishing royalties from a publication relating to health care.
Mark T. D'Esposito, MD, FAAN	No disclosure on file
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Hiroshi Mitsumoto, MD, FAAN	Dr. Mitsumoto has nothing to disclose.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Penelope Hogarth, MD	No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
James A. Mastrianni, MD, PhD	Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Jody Corey-Bloom, MD, PhD, FAAN	Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Jeffrey A. Kaye, MD, FAAN	Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Phyllis C. Zee, MD, PhD	Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Karen S. Marder, MD, MPH, FAAN	Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Bradford B. Worrall, MD, MSc, FAAN	The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Michael E. Shy, MD, FAAN	Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Kenneth H. Fischbeck, MD, FAAN	Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Omar A. Khan, MD, PhD	No disclosure on file
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Daniel Kaufer, MD, FAAN	No disclosure on file
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
William H. Theodore, MD, FAAN	Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities.
Charles W. Brock, MD	No disclosure on file
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
John C. Brust, MD	No disclosure on file
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
S. C. Johnston, MD, PhD, FAAN	No disclosure on file
Randolph S. Marshall, MD, FAAN	The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Mark F. Walker, MD	The institution of Dr. Walker has received research support from US Department of Veterans Affairs. Dr. Walker has received publishing royalties from a publication relating to health care. Dr. Walker has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer for Congressionally Directed Medical Research Program with General Dynamics Information Technology.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Kevin M. Flanigan, MD, FAAN	Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity.
Steven L. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has a non-compensated relationship as a Secretary General with World Federation of Neurology that is relevant to AAN interests or activities.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Pierre Fayad, MD, FAHA, FAAN	Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Israel Steiner, MD	No disclosure on file
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Merit E. Cudkowicz, MD, MSC, FAAN	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Bibiana Bielekova, MD, FAAN	Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Prakash Kotagal, MD, MBBS, FAAN	No disclosure on file
William Jagust, MD	No disclosure on file
Lael Stone, MD	No disclosure on file
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Richard J. Caselli, MD, FAAN	The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Patrick D. Lyden, MD, FAAN	Dr. Lyden has received personal compensation for serving as an employee of University of Southern Californiaq. Dr. Lyden has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apex Innovations. Dr. Lyden has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Lyden has received research support from NINDS.
Douglas R. Labar, MD, PhD	No disclosure on file
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Mark A. Ferrante, MD, FAAN	No disclosure on file
Bahman Jabbari, MD, FAAN	Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Eric M. Wassermann, MD	No disclosure on file
Ludwig Gutmann, MD, FAAN	Dr. Gutmann has a non-compensated relationship as a senior consulting editor (Humanities) with NEUROLOGY that is relevant to AAN interests or activities.
John A. Detre, MD	Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Linda S. Williams, MD, FAAN	The institution of Dr. Williams has received research support from VA HSR&D.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
David I. Kaufman, DO	Dr. Kaufman has nothing to disclose.
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Charles A. Thornton, MD, FAAN	Dr. Thornton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Thornton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Thornton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Thornton has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. Dr. Thornton has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pepgen. The institution of Dr. Thornton has received research support from Marigold Foundation. The institution of Dr. Thornton has received research support from NIH. The institution of Dr. Thornton has received research support from Muscular Dystrophy Association . The institution of Dr. Thornton has received research support from Dyne. The institution of Dr. Thornton has received research support from Avidity. The institution of Dr. Thornton has received research support from Ionis. Dr. Thornton has received intellectual property interests from a discovery or technology relating to health care.
Steven E. Arnold, MD	Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Daniel H. Lowenstein, MD	Dr. Lowenstein has received research support from NIH.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Cynthia Chin, MD	No disclosure on file
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Michael W. Weiner, MD	Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dolby Family Ventures. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuicals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoibnt. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin France. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quantum Leap Health. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sai MedPartners. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDA Corp.. Dr. Weiner has stock in Anven. Dr. Weiner has stock in Alzeca. Dr. Weiner has stock in Alzheon, Inc.. Dr. Weiner has stock in ALZpath. The institution of Dr. Weiner has received research support from NIH/NIA; National Institutes of Health/National Institutes of Aging. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Merck Sharp & Dohme. Dr. Weiner has received personal compensation in the range of $0-$499 for serving as a Speaker/Presenter with BrightFocus Foundation. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Banner Health.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
William D. Freeman, MD, FAAN	Dr. Freeman has nothing to disclose.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
Maarten G. Lansberg, MD	Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keating Jones Hughes. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chason, Rosner, Leary & Marshall. Dr. Lansberg has received publishing royalties from a publication relating to health care.
Suhayl S. Dhib-Jalbut, MD, FAAN	No disclosure on file
Ilia Itin, MD	No disclosure on file
Maria K. Houtchens, MD	Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Michael F. Waters, MD, PhD, FAAN	Dr. Waters has nothing to disclose.
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Ari Green, MD	Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Anthony Chen, MD	No disclosure on file
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Annette M. Langer-Gould, MD, PhD	An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Bernardino Ghetti, MD	No disclosure on file
Camilo E. Fadul, MD, FAAN	No disclosure on file
Luanne Metz, MD	The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Steven G. Younkin, MD, PhD	No disclosure on file
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Evgeny Tsimerinov, MD, PhD, FAAN	No disclosure on file
Andrew D. Barreto, MD	No disclosure on file
Charlene E. Hafer-Macko, MD	No disclosure on file
Bjorn E. Oskarsson, MD, FAAN	Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Christina Caon, RN, BS	Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Christen L. Shoesmith, MD, BSc, FAAN	The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to AAN interests or activities.
Joseph H. Friedman, MD, FAAN	No disclosure on file
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
John Cole, MD	Dr. Cole has nothing to disclose.
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Aneesh B. Singhal, MD, FAAN	An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (��ɫ��) with Biogen.
Laurie Gutmann, MD, FAAN	The institution of Dr. Gutmann has received research support from NIH. Dr. Gutmann has received publishing royalties from a publication relating to health care.
Michael A. De Georgia, MD	Dr. De Georgia has nothing to disclose.
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Christopher Bever, Jr., MD, MBA, FAAN	No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Timothy M. Miller, MD, PhD	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Bio. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. The institution of Dr. Miller has received research support from Ionis Pharmaceuticals . Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
J. Americo M. Fernandes, Jr., MD, FAAN	Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Meheroz H. Rabadi, MD, FAAN	Dr. Rabadi has nothing to disclose.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Hiroko H. Dodge, PhD	No disclosure on file
Glen M. Doniger, PhD	No disclosure on file
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Christoph Kleinschnitz, MD	Dr. Kleinschnitz has nothing to disclose.
James M. Gee	No disclosure on file
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Michael W. Henry	No disclosure on file
Nagaendran Kandiah, MD	No disclosure on file
Kimiaki Utsugisawa, MD, PhD	Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Yuriko Nagane, MD, PhD	No disclosure on file
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
James J. Lah, MD, PhD	Dr. Lah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. The institution of Dr. Lah has received research support from Roche.
Manoj Kumar	No disclosure on file
Helene Zephir	Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
	No disclosure on file
Katherine P. Rankin, PhD	The institution of Dr. Rankin has received research support from Marcus Foundation.
Maria Luisa Gorno Tempini, MD, PhD	The institution of Dr. Gorno Tempini has received research support from the NIH.
Sven Schippling	No disclosure on file
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
William W. Seeley, MD	Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Peter H. King, MD	The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
David P. Roeltgen, MD, FAAN	No disclosure on file
Antonio Federico, MD, Prof	No disclosure on file
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Ronald M. Lazar, PhD, FAHA, FAAN	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Ned C. Sacktor, MD, FAAN	No disclosure on file
Luca Durelli, MD	No disclosure on file
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Hayrettin Tumani, MD	Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Andrea Falini	No disclosure on file
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Niranjan N. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Gary Hunter, MD	No disclosure on file
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Jan Mares, MD	Dr. Mares has nothing to disclose.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Jose Luis Molinuevo	No disclosure on file
Frederic Blanc	No disclosure on file
Weihua Zhao, MD	No disclosure on file
David R. Beers, PhD	No disclosure on file
Mitch T. Wallin, MD, MPH, FAAN	The institution of Dr. Wallin has received research support from NMSS.
Cynthia L. Sullivan, PhD	No disclosure on file
Jeffrey A. Wilken, PhD	No disclosure on file
Gholam K. Motamedi, MD	Dr. Motamedi has nothing to disclose.
Saadat Kamran, MD	No disclosure on file
Dirk T. Deleu, MD, PhD, FRCP, FAAN	Dr. Deleu has nothing to disclose.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Philippe Cabre, MD	No disclosure on file
Olivier F. Gout, MD	Dr. Gout has nothing to disclose.
Howard Aizenstein, MD, PhD	No disclosure on file
Caterina Rosano, MD, MPH	No disclosure on file
Stuart D. Cook, MD, FAAN	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Mariet Allen, PhD	The institution of Dr. Allen has received research support from NIH. The institution of Dr. Allen has received research support from Florida Department of Health. Dr. Allen has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Kwang-Dong Choi, MD	No disclosure on file
Calin I. Prodan, MD	The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Cris S. Constantinescu, MD, PhD	Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Fen Bao	Fen Bao has nothing to disclose.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
Oezguer Yaldizli, MD	Dr. Yaldizli has nothing to disclose.
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Deborah Y. Bradshaw, MD, FAAN	The institution of Dr. Bradshaw has received research support from Alexion. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Richard S. Nicholas, FRCP	Dr. Nicholas has nothing to disclose.
Robert G. Smith, MD, PhD, FAAN	Dr. Smith has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Jonathan L. Carter, MD	Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Kazuo Fujihara, MD	Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Ichiro Nakashima, MD, PhD	Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Ging-Yuek R. Hsiung, MD, FAAN	Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Qin Li Jiang, MD	No disclosure on file
Roopali Gandhi, PhD	No disclosure on file
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Ralf Gold, MD, FAAN	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Andrew M. Naidech, MD, FAAN	Dr. Naidech has received publishing royalties from a publication relating to health care.
Adam Carpenter, MD	An immediate family member of Dr. Carpenter has received personal compensation for serving as an employee of MarPam Pharma. The institution of Dr. Carpenter has received research support from Roche. The institution of Dr. Carpenter has received research support from Immune Tolerance Network. The institution of an immediate family member of Dr. Carpenter has received research support from NIH.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Maria C. Zurru, MD	No disclosure on file
Edgardo Cristiano, MD	Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
John W. Lindsey, MD	Dr. Lindsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Lindsey has received research support from TG Therapeutics. The institution of Dr. Lindsey has received research support from CDMRP.
Sharon Ash	No disclosure on file
David Skoloudik, MD, PhD	No disclosure on file
Daniel Sanak	No disclosure on file
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
William E. Klunk, MD, PhD	No disclosure on file
Owen T. Carmichael, PhD	No disclosure on file
Joseph Herbert, MD	No disclosure on file
Dina Jacobs, MD	Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Clyde E. Markowitz, MD	No disclosure on file
Manuela Vaneckova	Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Brigitte Wildemann, MD	The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS, MSc has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck Foundation. Angela Vincent, MBBS, MSc has received intellectual property interests from a discovery or technology relating to health care.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Alexa Beiser	Alexa Beiser has nothing to disclose.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Bernhard Hemmer, MD	No disclosure on file
Ayse Altintas, MD	Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Arthur Toga	No disclosure on file
Claudia Cristina F. Vasconcelos, PhD	No disclosure on file
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Seung-Han Lee, MD, PhD	Dr. Lee has nothing to disclose.
M.T. Dotti, MD	No disclosure on file
Guillermo Videla, MD	No disclosure on file
Andrea Bozoki, MD, FAAN	Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector .
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Per Soelberg Sorensen	No disclosure on file
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Romain Marignier, MD, PhD	Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Christian A. Rosado, MD, FAAN	No disclosure on file
Ashfaq Shuaib, MD	Dr. Shuaib has nothing to disclose.
Christopher Scherfler, MD	No disclosure on file
Jin J. Luo, MD, PhD, FAAN	Dr. Luo has nothing to disclose.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Teresa Frohman, PA	No disclosure on file
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Sven O. Jarius, MD	Dr. Jarius has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Victoria Lawson, MD, FAAN	Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Andrew K. Dorsch, MD	No disclosure on file
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Bernadette Boden-Albala, DrPH	Ms. Boden-Albala has nothing to disclose.
Violaine K. Harris, PhD	No disclosure on file
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has nothing to disclose.
Minerva Carrasquillo	The institution of Minerva Carrasquillo has received research support from NIA. The institution of Minerva Carrasquillo has received research support from Carl Angus DeSantis Foundation. The institution of Minerva Carrasquillo has received research support from Florida Department of Health. Minerva Carrasquillo has received personal compensation in the range of $500-$4,999 for serving as a Reviewer for Study Section with NIH.
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Deanna Saylor, MD, MHS, FAAN	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Jerry Lin, BS	Mr. Lin has nothing to disclose.
Lisa Silbert, MD, FAAN	The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Alireza Atri, MD, PhD	Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Atri has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lunbeck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. The institution of Dr. Atri has received research support from National Institute of Aging (NIA). The institution of Dr. Atri has received research support from AZ Department of Health Services. The institution of Dr. Atri has received research support from Gates Ventures. The institution of Dr. Atri has received research support from Multiple companies, universities & consortia for contracted clinical trials to institution. The institution of Dr. Atri has received research support from Washington University in St. Louis. The institution of Dr. Atri has received research support from Foundation for NIH. The institution of Dr. Atri has received research support from ACTC/NIH. Dr. Atri has received publishing royalties from a publication relating to health care.
Deniz Erten-Lyons, MD, FAAN	Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.
Acary S. Oliveira, MD	No disclosure on file
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Michael Greicius, MD	Dr. Greicius has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acelot.
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Lynn Stazzone, RN	Ms. Stazzone has nothing to disclose.
Jeffrey C. Wagner, MD	Dr. Wagner has nothing to disclose.
Jessica D. Lee, MD, FAAN	Dr. Lee has received personal compensation for serving as an employee of ��ɫ��. The institution of Dr. Lee has received research support from Janssen.
Robert H. Edwards, MD	No disclosure on file
Regina Alvarenga, MD	No disclosure on file
Jerome J. Graber, MD, MPH, FAAN	Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with ��ɫ�� that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Dawn O. Kleindorfer, MD, FAAN	Dr. Kleindorfer has nothing to disclose.
Kathleen Alwell	No disclosure on file
Ian R.A. Mackenzie, MD, FRCP	No disclosure on file
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Frauke Zipp, MD	Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Orhan Aktas, MD	Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Salvatore Spina, MD	Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert.io. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lumanity. Dr. Spina has received research support from Tau Consortium. Dr. Spina has received research support from Chan Zuckerberg Initiative, LLC. Dr. Spina has received research support from Bluefield Project to Cure FTD. Dr. Spina has received research support from NIH. Dr. Spina has received research support from Larry L. Hillblom Foundation. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Peking Union Medical Center Hospital.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
George Dale	George Dale has nothing to disclose.
Joshua Z. Willey, MD, FAAN	Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Andrea Vincent	Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
Silvia Tenembaum, MD	Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. .
Eric M. Reiman, MD	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Michael Dobbs, MD	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Fiona E. Costello, MD	Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Brian Scott, MD	Dr. Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend Biotech.
William A. Sheremata, MD	No disclosure on file
Anthony S. Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine: Journal Watch. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Quintairos, Prieto, Wood & Boyer, PA. The institution of Dr. Kim has received research support from NIH/NCATS. The institution of Dr. Kim has received research support from NIH/NINDS. The institution of Dr. Kim has received research support from NIH/NIHMD. The institution of Dr. Kim has received research support from Patient-Centered Outcome Research Institute. The institution of Dr. Kim has received research support from American Heart Association. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Neurological Association.
Gary W. Small, MD	No disclosure on file
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Ann Scher, PhD, FAAN	No disclosure on file
Kate Bushby, MD	Dr. Bushby has nothing to disclose.
Samuel A. Frank, MD, FAAN	Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Fay B. Horak, PhD	No disclosure on file
Joseph Y. Matsumoto, MD	Dr. Matsumoto has nothing to disclose.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
S. A. Josephson, MD, FAAN	Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Janice Y. Maldonado, MD	The institution of Dr. Maldonado has received research support from Genentech.
Pierre Duquette, MD	The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Jean-Pascal Lefaucheur	No disclosure on file
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Hiroyuki Murai, MD	Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Jan Krasensky, MD	No disclosure on file
Stephen M. Graham, PhD	No disclosure on file
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care.
Amy Pace, ScD	No disclosure on file
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Francois Grand-Maison, MD	Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Stephen J. Howell, MD	No disclosure on file
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Robert Hyde, PhD	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Klaus Berger, MD	No disclosure on file
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Vanja C. Douglas, MD, FAAN	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Sheryl Martin-Schild, MD, PhD, FAAN	No disclosure on file
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Hikoaki Fukaura, MD	No disclosure on file
Benito P. Damasceno, MD, PhD	No disclosure on file
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Barbara A. Dworetzky, MD, FAAN	Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Tiffini S. Voss, MD	No disclosure on file
Alex D. Rae-Grant, MD, FRCPC, FAAN	Dr. Rae-Grant has received publishing royalties from a publication relating to health care. Dr. Rae-Grant has received publishing royalties from a publication relating to health care.
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Walter R. Royal III, MD	No disclosure on file
Innocenzo Rainero, MD, PhD	No disclosure on file
Lorenzo Pinessi, MD	No disclosure on file
Emilia M. Gatto, MD, FAAN	Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Roy H. Hamilton, MD, MS, FANA, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Milena Pavlova, MD	Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pear Therapeutics. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Oakstone. The institution of Dr. Pavlova has received research support from Jazz. The institution of Dr. Pavlova has received research support from Vanda. The institution of Dr. Pavlova has received research support from Biomobie. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving as a Didactic article with Neurodiem.
Dimitri M. Kullmann	No disclosure on file
Jean C. Ouallet	Jean C. Ouallet has nothing to disclose.
Carla Tortorella	No disclosure on file
Amilton A. Barreira, MD	No disclosure on file
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN	The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Andres M. Villa, MD	Dr. Villa has nothing to disclose.
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Cristin McKenna	No disclosure on file
Christian J. Lueck, MD, FAAN	No disclosure on file
Marilou I. Ching, MD	Dr. Ching has nothing to disclose.
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Sophie Pittion	Sophie Pittion has nothing to disclose.
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Alfredo Damasceno, MD	No disclosure on file
Elisa Rubino, MD	No disclosure on file
Sanjeev Sivakumar, MD	Dr. Sivakumar has stock in LLY. Dr. Sivakumar has stock in Abbott Labs. Dr. Sivakumar has stock in Abbvie.
Eric Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Daniela Perani, MD	No disclosure on file
Naveed Akhtar, MD, FAAN	Dr. Akhtar has nothing to disclose.
Daniel Blackburn, MD	No disclosure on file
Bruno Coutinho, MD	No disclosure on file
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
William J. Culpepper II, PhD, MA	No disclosure on file
Jose Luis Etcheverry, MD	No disclosure on file
Joseph Finkelstein	No disclosure on file
Jill S. Goldman, MS MPhil CGC	No disclosure on file
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Anu Jacob, MD	Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Virginia Lee, PhD	Virginia Lee, PhD has nothing to disclose.
Yasutoshi Koga, MD, PhD	No disclosure on file
Michal Kral	No disclosure on file
Jeannette Lechner-Scott, MD, PhD, FRACP	The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Rosa Rademakers, PhD	Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FANA, FAAN	Dr. Ramachandiran has nothing to disclose.
Michael Potchen	No disclosure on file
Manish Modi, MD	Dr. Modi has nothing to disclose.
Wilson Marques, Jr., MD	Dr. Marques has nothing to disclose.
Herbert Schreiber	Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Anna Schubart	No disclosure on file
Steven Jacobson	Steven Jacobson has nothing to disclose.
Seema K. Tiwari-Woodruff, PhD	No disclosure on file
Sandra Vanotti, MD	No disclosure on file
Molly Zimmerman	No disclosure on file
Nupur Ghoshal, MD, PhD	Dr. Ghoshal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BCBSA. The institution of Dr. Ghoshal has received research support from NIH. The institution of Dr. Ghoshal has received research support from AFTD. The institution of Dr. Ghoshal has received research support from Tau Consortium/ Rainwater Charitable Foundation. Dr. Ghoshal has received intellectual property interests from a discovery or technology relating to health care.
Christopher D. Lee, MD	Dr. Lee has nothing to disclose.
James F. Bartscher, MD	Dr. Bartscher has nothing to disclose.
Susan Shaw, MD	No disclosure on file
Bryan T. Klassen, MD	The institution of Dr. Klassen has received research support from Insightec.
Igor J. Koralnik, MD, FAAN	Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
David Y. Huang, MD, PhD, FAAN	Dr. Huang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReNeuron. Dr. Huang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KMPHC.
David N. Franz, MD	No disclosure on file
Jiong Shi, MD, FAAN	Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Duarte G. Machado, MD, FAAN	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal.
Masakatsu Motomura, MD	No disclosure on file
Klaus Seppi, MD	Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Jordan Grafman, PhD	Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
Joachim M. Baehring, MD, FAAN	Dr. Baehring has nothing to disclose.
Barbara Teter, PhD MPH	No disclosure on file
Erwin B. Montgomery, Jr., MD	No disclosure on file
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Craig McDonald, MD	Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Flavia Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Christopher Severson, MD	Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Herminia D. Rosas, MD	No disclosure on file
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Phyllis Faust	Phyllis Faust has nothing to disclose.
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Randall L. Woltjer	Randall L. Woltjer has nothing to disclose.
Derya Kaya	No disclosure on file
Valeria Paula Fazan, MD, PhD	No disclosure on file
Susan M. Resnick, PhD	No disclosure on file
Liat Hayardeny Nisimov, PhD	No disclosure on file
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Miho Murata	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Eva Krasulova, MD	No disclosure on file
Sara B. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Joseph Giuffrida, PhD	No disclosure on file
Alessandra Lugaresi, MD	Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Antonio Uccelli, MD	An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Jodie Burton, MD, FAAN	Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a ��ɫ��al Chair with EMD Serono that is relevant to AAN interests or activities.
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Galeno Rojas, MD	No disclosure on file
Jennifer Vannest	No disclosure on file
Jun Shimizu, MD, PhD	No disclosure on file
John Kornak	No disclosure on file
Christopher Coffey, PhD, FAAN	Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Stacey Cofield	No disclosure on file
Edward Huey	No disclosure on file
Dorothea A. Buck, MD	No disclosure on file
Chad Hoyle, MD	Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Amy Conger	No disclosure on file
Juan Ignacio Rojas, MD	Dr. Rojas has nothing to disclose.
Carolin Dohle, MD	Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Jan-Markus Doerr	No disclosure on file
Guillermo Povedano, MD	No disclosure on file
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Fabio M. Iwamoto, MD	No disclosure on file
Arunodaya R. Gujjar, MBBS, DM, FRCP	Dr. Gujjar has nothing to disclose.
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Susan Landau, PhD	Dr. Landau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KeifeRx. Dr. Landau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai, Inc. The institution of Dr. Landau has received research support from NIH.
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Glenn D. Graham, MD, PhD, FAAN	Dr. Graham has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with MER (non-profit CME provider). Dr. Graham has received personal compensation in the range of $500,000-$999,999 for serving as a Employee with Department of Veterans Affairs. An immediate family member of Dr. Graham has received personal compensation in the range of $100,000-$499,999 for serving as a Exployee with Department of Veterans Affairs.
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN	Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wellcome Trust. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from Rosetrees Trust. The institution of Dr. De Luca has received research support from Strategic Innovation Fund, Oxford University. The institution of Dr. De Luca has received research support from Agence National de la Recherche. Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Continuum (AAN) that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Frontiers in Neurology that is relevant to AAN interests or activities.
Masashi Aoki, MD, PhD	Masashi Aoki, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tanabe Mitsubishi.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Jacqueline Bernard, MD, FAAN	Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2ND MD. Dr. Bernard has received publishing royalties from a publication relating to health care.
Achim Berthele, MD	No disclosure on file
Ana Belen Caminero Rodriguez, MD	Dr. Caminero Rodriguez has nothing to disclose.
Ellen Carl, MS	No disclosure on file
Sylvia R. Delgado, MD, FAAN	The institution of Dr. Delgado has received research support from Novartis. The institution of Dr. Delgado has received research support from EMD Serono.
Marc Dinkin, MD	Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
Ramy El Khoury, MD, FAAN	No disclosure on file
Pamela Federighi	No disclosure on file
Jithin S. George, MD	No disclosure on file
Jeremy C. Hobart, MD	Dr. Hobart has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Hobart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
David Y. Hwang, MD, FAAN	The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
Fethi Idiman, MD	No disclosure on file
Hong Jiang, MD, PhD	The institution of Dr. Jiang has received research support from Florida Health. The institution of Dr. Jiang has received research support from NINDS RO1.
Joanna Kitley, MD	No disclosure on file
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Fred A. Lado, MD	Dr. Lado has a non-compensated relationship as a Board Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Lado has a non-compensated relationship as a Officer with National Association of Epilepsy Centers that is relevant to AAN interests or activities.
Tanya J. Lehky, MD	Dr. Lehky has nothing to disclose.
Shifang Liu	No disclosure on file
Rimas V. Lukas, MD	Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Matthew Maas, MD, FAAN	The institution of Dr. Maas has received research support from National Institutes of Health.
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Stephen J. Marks, MD	No disclosure on file
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
James McNames	No disclosure on file
Luciana Melamud	No disclosure on file
Masahito Mihara, MD, PhD	No disclosure on file
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Gregory Norris, MD	No disclosure on file
Milvia Y. Pleitez, MD	An immediate family member of Dr. Pleitez has received stock or an ownership interest from Medtronic. Dr. Pleitez has received stock or an ownership interest from Abbvie. An immediate family member of Dr. Pleitez has received stock or an ownership interest from Merck. Dr. Pleitez has received stock or an ownership interest from QualCom.
Virginia A. Pujol Lereis, MD	Dr. Pujol Lereis has nothing to disclose.
Venkat Ramani, MD, FAAN	No disclosure on file
Pawan V. Rawal, MD	No disclosure on file
Michael Schroeter	No disclosure on file
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Elena Shanina, MD, FAAN	Dr. Shanina has nothing to disclose.
Peyman Shirani, MD	No disclosure on file
Andrew Solomon, MD, FAAN	Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Steven P. Sparagana, MD, FAAN	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
Sana Syed, MD	Dr. Syed has received personal compensation for serving as an employee of Sanofi US.
Charles A. Szabo, MD, FAAN	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Yoshiki Takai, MD	No disclosure on file
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Richard M. Tsai, MD	Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has or had stock in Angle Therapeutics.Dr. Johnson has or had stock in Juvena Therapeutics.Dr. Johnson has or had stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Rosa Capozzo	No disclosure on file
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Giovanni L. Mancardi	No disclosure on file
Elia M. Pestana Knight, MD	Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus Pharmaceuticals.
Soojin Park, MD	Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Farzad Moien Afshari, MD	No disclosure on file
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Abdullah Al-Asmi, MD	No disclosure on file
Haralambos Alexopoulos	No disclosure on file
Jane B. Allendorfer, PhD	The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Nazely Ashikian, MD	Dr. Ashikian has nothing to disclose.
Francois-Jer Authier, MD	No disclosure on file
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Roumen D. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Lauren Reoma, MD, FAAN	Dr. Reoma has received research support from NIH. Dr. Reoma has a non-compensated relationship as a Vice Chair with AAN Experimental Neurotherapeutics Section that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Federal Employee with NINDS/NIH that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Member with ASENT Program Committee that is relevant to AAN interests or activities.
Alexander U. Brandt, MD	No disclosure on file
Jeremy D. Burgess	No disclosure on file
Peii Chen	No disclosure on file
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Romain Gherardi, MD	No disclosure on file
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Mark Hellman	Mark Hellman has nothing to disclose.
Jayandra Himali	Jayandra Himali has nothing to disclose.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Gareth R. John	No disclosure on file
Darcy Krueger, MD	Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Maria I. Leite, MD	The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.
Su-Yin Lim, MBBS	No disclosure on file
Charles Maitland	No disclosure on file
David A. Marks, MD	Dr. Marks has nothing to disclose.
Saul Martinez-Horta	No disclosure on file
Dominick J. McCabe, MD, PhD	No disclosure on file
Sonal Mehta, MD	Dr. Mehta has nothing to disclose.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Phillip C. Mongiovi, MD	Dr. Mongiovi has nothing to disclose.
Heather Moss, MD, PhD, FAAN	Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Francesco Muntoni, MD	Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Ib R. Odderson, MD, PhD	No disclosure on file
Juan A. Ollari, MD, FAAN	No disclosure on file
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Francesca Rosini, MD	No disclosure on file
Aisling Ryan, PhD, MB, FRCPI	Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Emmanuel O. Sanya, MD	No disclosure on file
Leslie M. Shaw, PhD	Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Shaw has received research support from NIA. The institution of Dr. Shaw has received research support from MJ Fox foundation for Parkinsons Research.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP	The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Waimei A. Tai, MD, FAAN	Dr. Tai has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore. Dr. Tai has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple firms.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Rana Karabudak, MD	Dr. Karabudak has nothing to disclose.
James Brewer, MD, PhD	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
William Rooney, PhD	Dr. Rooney has nothing to disclose.
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN	Dr. Von Glehn Silva has nothing to disclose.
J M. Girard, MD	Dr. Girard has nothing to disclose.
Madaline B. Harrison, MD	Dr. Harrison has nothing to disclose.
James R. Brorson, MD	Dr. Brorson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Peer Review Corporation. Dr. Brorson has a non-compensated relationship as a Vascular Neurology Pilot Committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Alexander Dressel, MD	No disclosure on file
Kazuko Hasegawa, MD	Dr. Hasegawa has nothing to disclose.
Jan N. Lycke, MD	Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
Jennifer DeWolfe, DO	No disclosure on file
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
David Pitt, MD	Dr. Pitt has nothing to disclose.
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Asma Zakaria, MD	Dr. Zakaria has received publishing royalties from a publication relating to health care.
Jihad S. Inshasi, MD, MBBS, FAAN	Dr. Inshasi has nothing to disclose.
Ingo Kleiter	No disclosure on file
Teri Schreiner, MD, MPH, FAAN	The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Zachary Miller, MD	Dr. Miller has nothing to disclose.
Binit Shah, MD, FAAN	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Peter Turkeltaub, MD, PhD	Dr. Turkeltaub has nothing to disclose.
Michaela Tyblova	No disclosure on file
Raya Massoud, MD	No disclosure on file
Wondwossen G. Tekle, MD	Dr. Tekle has nothing to disclose.
Pablo B. Winckler, MD, PhD	Dr. Winckler has nothing to disclose.
Channa Kolb, MD	No disclosure on file
Anthony Feinstein, MD	Anthony Feinstein, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Biogen, Roche and Sanofi-Genzyme. The institution of Anthony Feinstein, MD has received research support from Multiple Sclerosis Society of Canada. Anthony Feinstein, MD has received publishing royalties from a publication relating to health care.
Douglas K. Sato, MD	Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra-Zeneca. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
Egemen Idiman, MD	No disclosure on file
Vojislav Pejovic, PhD	No disclosure on file
Richard Salazar, MD, FAAN	No disclosure on file
Paul Gilbert, PhD	Dr. Gilbert has nothing to disclose.
Ashkan Mowla, MD, FAAN	No disclosure on file
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Srivadee Oravivattanakul, MD	Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
Laxmi P. Dhakal, MD	No disclosure on file
Pavan Bhargava, MD, FAAN	The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Katherine L. Possin, PhD	Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Maureen A. Mealy, PhD, RN	No disclosure on file
Anik Amin, MD	Dr. Amin has nothing to disclose.
Anantha Vellipuram, MD	Dr. Vellipuram has nothing to disclose.
Prachi Mehndiratta, MD	Dr. Mehndiratta has nothing to disclose.
I-Hui Lee, MD, PhD	Dr. Lee has nothing to disclose.
Ilya Ayzenberg	Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Ayzenberg has received research support from Diamed.
Paula C. Azevedo, MD	Dr. Azevedo has nothing to disclose.
Bertrand Bourre	Bertrand Bourre has nothing to disclose.
Carlos Otavio Brandao, MD, PhD	No disclosure on file
Meredith N. Braskie	No disclosure on file
Giles Campion, MD, PhD	No disclosure on file
Darrel Conger	No disclosure on file
Caterina Garone	No disclosure on file
Rachel P. Guimaraes, PT	Ms. Guimaraes has nothing to disclose.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Michael L. Lipton, MD, PhD	No disclosure on file
Eric A. Macklin, PhD	The institution of Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AI Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe Pharmaceuticals America. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from UCB Ra Pharma. The institution of Dr. Macklin has received research support from Revalesio. The institution of Dr. Macklin has received research support from Seelos. The institution of Dr. Macklin has received research support from Calico. The institution of Dr. Macklin has received research support from Denali. The institution of Dr. Macklin has received research support from NeuroDex. The institution of Dr. Macklin has received research support from Alector. The institution of Dr. Macklin has received research support from ITB-Med.
Zuzana Matejcikova	No disclosure on file
Emiliya Melkumova, MD	Dr. Melkumova has nothing to disclose.
Katherine Nearing, MD	Dr. Nearing has nothing to disclose.
Timm Oberwahrenbrock, PhD	No disclosure on file
Santiago Pigretti	No disclosure on file
Luiza G. Piovesana, MD	No disclosure on file
Delaram Safarpour, MD, MSCE, FAAN	Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Safarpour has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Safarpour has received research support from Medtronic. The institution of Dr. Safarpour has received research support from Amneal. The institution of Dr. Safarpour has received research support from CND life science.
Timothy Spelman	No disclosure on file
Virginia Sturm, PhD	Dr. Sturm has nothing to disclose.
Melih Tutuncu, MD	No disclosure on file
Elena Ratti, MD	Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Meghan Harris, MD	No disclosure on file
Shirley H. Wray, MD, PhD, FAAN	No disclosure on file
Hsinlin T. Cheng, MD, FAAN	Dr. Cheng has nothing to disclose.
Konrad Schlick, MD, FAAN	Dr. Schlick has nothing to disclose.
Brian S. Katz, MD	No disclosure on file
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Michelle P. Kvalsund, DO	Dr. Kvalsund has nothing to disclose.
Priyanka P. Shah-Basak, PhD	The institution of Dr. Shah-Basak has received research support from NIH NIDCD. The institution of Dr. Shah-Basak has received research support from NIH NIDCD.
Shin C. Beh, MD, FAAN	Dr. Beh has received publishing royalties from a publication relating to health care.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Monica E. Loghin, MD	Dr. Loghin has nothing to disclose.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Amit Chaudhari, MD, PhD	No disclosure on file
Babar Khokhar, MD, FAAN	Dr. Khokhar has nothing to disclose.
Deepti Anbarasan, MD	Dr. Anbarasan has nothing to disclose.
James D. Berry, MD MPH	Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Winston Chiong, MD	The institution of Dr. Chiong has received research support from the National Institutes of Health. The institution of Dr. Chiong has received research support from the Dana Foundation. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health.
Bryan Smith, MD	Dr. Smith has nothing to disclose.
Linda P. Lowes, PT PhD	The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Katya Rascovsky	No disclosure on file
Daphne Robakis, MD	Dr. Robakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal pharmaceuticals.
Gulshan Uppal, MD, FAAN	Dr. Uppal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Uppal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Helen Ly, MD	No disclosure on file
Pravin George, DO	Dr. George has nothing to disclose.
Meryl A. Butters	No disclosure on file
David S. Kushner, MD, FAAN	Dr. Kushner has nothing to disclose.
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Mitchell M. Danesh, MD	Dr. Danesh has nothing to disclose.
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Salim Chahin, MD	Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutic . The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
Suhail Al Rukn, MD, FRCPC	No disclosure on file
Markus Reuber	No disclosure on file
Rocio Hernandez Clares, MD, PhD	No disclosure on file
Itay Lotan, MD	Dr. Lotan has nothing to disclose.
Adnan I. Khan, MD	No disclosure on file
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Brianne Bettcher	No disclosure on file
Jennifer S. Yokoyama, PhD	The institution of Dr. Yokoyama has received research support from NIH. The institution of Dr. Yokoyama has received research support from Alzheimer's Association . The institution of Dr. Yokoyama has received research support from Mary Oakley Foundation. The institution of Dr. Yokoyama has received research support from Alector. The institution of Dr. Yokoyama has received research support from Transposon. The institution of Dr. Yokoyama has received research support from Rainwater Charitable Foundation.
Jesper Hagemeier	No disclosure on file
Jingya Zhang, PhD	No disclosure on file
Joseph Duffy	The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Kartik Raghupathi	No disclosure on file
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Marius Ringelstein	Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Massimiliano Cristofanilli, PhD	No disclosure on file
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Roopali Ghandi	No disclosure on file
Shivam O. Mittal, MD, FAAN	Dr. Mittal has nothing to disclose.
Tarah Gustafson	No disclosure on file
Leticia Tornes, MD, FAAN	Dr. Tornes has nothing to disclose.
Matthew E. Fink, MD, FAAN	Dr. Fink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Relias LLC.
Natalie R. Weathered, MD, FAAN	Dr. Weathered has nothing to disclose.
Abubaker Almadani, MD	No disclosure on file
Sajish Jacob, MBBS	No disclosure on file
Nathaniel M. Robbins, MD	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Laura Wilson, MD	No disclosure on file
Samuel Yip, MD, PhD	Dr. Yip has nothing to disclose.
Joao M. Lemos, MD	No disclosure on file
Imad R. Khan, MD	The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke. The institution of Dr. Khan has received research support from National Heart Lung and Blood Institute. The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Dara V. Albert, DO, FAAN	Dr. Albert has nothing to disclose.
Christoph Heesen	No disclosure on file
Melissa R. Ortega, MD	An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Aptitude. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Oncocyte. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Total Health Information.
David R. Benavides, MD, PhD, FAAN	The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd.
David J. Roh, MD	Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Michelle Bell, MD	Dr. Bell has nothing to disclose.
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Jennie Valles, MD	No disclosure on file
Sheetal Shroff, MD	Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Laura Bishop, DO	No disclosure on file
Eric Liotta, MD	Dr. Liotta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. The institution of Dr. Liotta has received research support from NIH-NINDS.
Rajan K. Patel, MD	No disclosure on file
Luciana Catanese, MD	Dr. Catanese has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IschemiaCare.
Karin Mente, MD	Dr. Mente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spear Bio. The institution of Dr. Mente has received research support from National Institute on Aging. The institution of Dr. Mente has received research support from Michael J Fox Foundation.
Rick Magun, MD	Dr. Magun has nothing to disclose.
Simon Broadley, PhD, FRACP	The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC.
Alessandra Rufa, MD, PhD	No disclosure on file
Christopher Olm	No disclosure on file
Mani K. Nezhad, MD	No disclosure on file
Sourabh Lahoti, MD	No disclosure on file
Alexander George	No disclosure on file
Collin H. York	No disclosure on file
Dorlan J. Kimbrough, MD	Dr. Kimbrough has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CVS.
Marc Diamond, MD	The institution of Dr. Diamond has received research support from NIH. Dr. Diamond has received intellectual property interests from a discovery or technology relating to health care.
Ilan J. Danan, MD	Dr. Danan has received personal compensation for serving as an employee of National Football League. Dr. Danan has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Ilan J Danan MD INC.
Jeffrey Kim, MD	No disclosure on file
Yuebing Li, MD, PhD, FAAN	Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Vijayakumar Javalkar, MD, MCh, FAAN	Dr. Javalkar has nothing to disclose.
Michael R. Silver, MD	Dr. Silver has nothing to disclose.
Emil Gaitour, MD	No disclosure on file
Neha Mirchandani, MD	No disclosure on file
Rachel Nolan	Ms. Nolan has nothing to disclose.
Laurie A. Schluter, RN, MSN, FNP	No disclosure on file
Meiko Maeda, MD, PhD	No disclosure on file
Bertrand Audoin	No disclosure on file
Nadja Borisow	No disclosure on file
Ali Ezzati, MD	The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Alessandro S. Farias, PhD	No disclosure on file
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Michaela Kachadoorian	No disclosure on file
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Elisabeth Maillart	No disclosure on file
Stefania Maraka, MD	Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SpringWorks Therapeutics . The institution of an immediate family member of Dr. Maraka has received research support from Baxter.
Maria Antonietta Mazzola, MD	Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
Thibault Moreau	Thibault Moreau has nothing to disclose.
Paolo Muraro	Paolo Muraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Pinsent Masons LLP. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Taylor Wessing LLP. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bugge Valentin. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lambert Hornby LLP. The institution of Paolo Muraro has received research support from NIHR-EME. The institution of Paolo Muraro has received research support from Benaroya Research Institute.
Rajani Sebastian, PhD	No disclosure on file
Vishal Shah, MBBS, FAAN	Dr. Shah has nothing to disclose.
Recai Turkoglu	Recai Turkoglu has nothing to disclose.
Vernice E. Bates, MD	No disclosure on file
Dennis Dietrich, MD	No disclosure on file
Edward M. Kaye, MD	No disclosure on file
John M. Hourihane, MD	No disclosure on file
Abuhuzeifa Abubakr, MB, FRCP, FRCPI, FAAN	No disclosure on file
Michael C. Tierney, MA	No disclosure on file
Ann D. Bass, MD	Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Ami K. Mankodi, MD, FAAN	No disclosure on file
Judith A. Clark	No disclosure on file
Karen M. Weidenheim, MD	No disclosure on file
Yasar Zorlu, MD	No disclosure on file
Squire M. Stead, MD, PhD	No disclosure on file
Alberto Esquenazi, MD	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Michael Lang	No disclosure on file
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
Heather Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Rainer W. Paine, MD, PhD	No disclosure on file
Joel Salinas, MD, MBA, MSc, FAAN	Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Sean Rogers, MD, PhD	No disclosure on file
Francis M. Gengo, PharmD	No disclosure on file
Bridgette J. Billioux, MD	Dr. Billioux has nothing to disclose.
Ramsey A. Falconer, MD, FAAN	Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. The institution of Dr. George has received research support from American Heart Associate. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.
Kara A. Sands, MD	Dr. Sands has nothing to disclose.
Clara Boyd, MD	No disclosure on file
Radu Tanasescu, MD, PhD, FAAN	Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Shaheryar Hafeez, MD	Dr. Hafeez has nothing to disclose.
Ivana Vodopivec, MD	Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Adrian L. Oblak, PhD	No disclosure on file
Virginia Laura Parisi, MD	No disclosure on file
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Eva Costa Arpin, MD	No disclosure on file
Lauren M. Massimo, PhD	No disclosure on file
Johanna Hamel, MD	Dr. Hamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals.
Aradia Fu, MD	No disclosure on file
Sonia N. Krish, MD	No disclosure on file
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Ali Saeed, MD	No disclosure on file
Amy Chan, MD	Dr. Chan has nothing to disclose.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. The institution of Dr. Bhattacharyya has received research support from TG Therapeutics. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Pooja S. Raibagkar, MD	Dr. Raibagkar has nothing to disclose.
Manan Shah, MD, MBBS	Dr. Shah has nothing to disclose.
Patricio Chrem Mendez, MD	Dr. Chrem Mendez has nothing to disclose.
Myassar Zarif	Myassar Zarif has nothing to disclose.
Maria Cristina Arci Santos	No disclosure on file
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Hiroshi Kuroda, MD	No disclosure on file
Ignacio Demey, MD, PhD	Ignacio Demey, MD, PhD has received personal compensation for serving as an employee of IQVIA.
Joan Largent, PhD	No disclosure on file
Kaustubh S. Limaye, MD	Dr. Limaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scientia Vascular.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Jared Noroozi, MD	No disclosure on file
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Grace Paley, MD, PhD	No disclosure on file
Xiaoli Yu, PhD	The institution of Dr. Yu has received research support from NIH.
Ahmed A. Malik, MD	No disclosure on file
Alyana Samai	No disclosure on file
Andrew Herndon	No disclosure on file
Babatunde A. Ademiluyi, MD	No disclosure on file
Benjamin Pagano	No disclosure on file
Brian Harel, PhD	Brian Harel, PhD has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel, PhD has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel, PhD has or had stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel, PhD has or had stock in Eli Lilly, Pfizer, Astra Zeneca.Brian Harel, PhD has or had stock in Cogstate.
Chiseko Ikenaga, MD, PhD	Dr. Ikenaga has nothing to disclose.
Christopher Sears	No disclosure on file
Damoun Safarpour, MD, PhD	No disclosure on file
Daniel Gratch	No disclosure on file
David Miller	No disclosure on file
David C. Zhu, PhD	No disclosure on file
Donna Tippett	No disclosure on file
Elena Pretegiani	No disclosure on file
Sanjana Salwi	No disclosure on file
Erica S. Westphal	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Whitney R. Fitts, MD	No disclosure on file
Emma Meyers, MD	No disclosure on file
Felipe S. Vianna, MD	No disclosure on file
Geidy Serrano	Geidy Serrano has nothing to disclose.
Gilles Edan	Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Hanane Touil, PhD	No disclosure on file
Harry Alexopoulos	No disclosure on file
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Katelyn S. Kavak	Ms. Kavak has nothing to disclose.
Kerstin Goebel	No disclosure on file
Margaret Esiri	Margaret Esiri has stock in Cytox Group.
Tiffany Duong, MD	No disclosure on file
Mark Landy	No disclosure on file
Marwan Alahiri	No disclosure on file
Matteo Pardini, MD, PhD	No disclosure on file
Matthieu Bereau	Matthieu Bereau has nothing to disclose.
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Peng Cheng Han, PhD	No disclosure on file
Rhonda Friedman, PhD	No disclosure on file
Samuel Arnow	No disclosure on file
Satoru Tanaka, MD	No disclosure on file
Mitchell Silver, MD	Dr. Silver has nothing to disclose.
Sofia Akrivou	No disclosure on file
Tania Garcia	No disclosure on file
William Baskett	No disclosure on file
Tiffany K. Grider, MS, CGC	Ms. Grider has received personal compensation in the range of $0-$499 for serving as a author of educational material with Muscle Dystrophy Association.
Tomas Uher	Tomas Uher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol myers. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Tomas Uher has received research support from Novartis.
Wemimo Alaofin, MD	No disclosure on file
Ying Liu, PhD	No disclosure on file
Zilfah Younus, MD	No disclosure on file
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Maria Del Mar Mendibe Bilbao	No disclosure on file
Martin E. Brown, MD	Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with University of Louisville.
Melissa Elafros, MD, PhD	The institution of Dr. Elafros has received research support from National Institute of Neurologic Disorders and Stroke . The institution of Dr. Elafros has received research support from National Center for Advancing Translational Sciences. The institution of Dr. Elafros has received research support from National Institute of Diabetes and Digestive and Kidney Diseases .
Emily Brereton	Emily Brereton has nothing to disclose.
Omar Siddiqi, MD	The institution of Dr. Siddiqi has received research support from NIH.
Charlotte S. Herber	No disclosure on file
Andrea C. Adams, MD	Dr. Adams has nothing to disclose.
Gregory S. Carter, MD, PhD	No disclosure on file
Judd M. Jensen, MD	Dr. Jensen has nothing to disclose.
Owen B. White, MD, PhD	No disclosure on file
Steven M. Hersch, MD, PhD	Dr. Hersch has received personal compensation for serving as an employee of Eisai Inc.. Dr. Hersch has stock in Voyager Therapeutics. The institution of an immediate family member of Dr. Hersch has received research support from NIH. Dr. Hersch has received intellectual property interests from a discovery or technology relating to health care.
Francisco R. Torres, MD	No disclosure on file
Nancy B. Isenberg, MD, MPH, FAAN	No disclosure on file
Charles Tilbery, MD	No disclosure on file
J. M. Sliwinski, PhD	No disclosure on file
Cristina Januario, MD	No disclosure on file
Luis Amaya Sanchez, MD	No disclosure on file
Susana Ochoa, MD	No disclosure on file
Jacob A. Sloane, MD, PhD	Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
John Edwards	No disclosure on file
Guillaume Bassez, MD	No disclosure on file
John F. Ryan	No disclosure on file
Luca Roccatagliata, MD	No disclosure on file
Javier Jose Mallada	No disclosure on file
Andrew R. Hughes, MBBS	No disclosure on file
Melinda Carter, MSN ARNP	No disclosure on file
Moises Garces, MD	No disclosure on file
Shlee S. Song, MD	Dr. Song has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS. Dr. Song has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA/ASA. Dr. Song has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hodes Milman. The institution of Dr. Song has received research support from DISCOVERY.
Ahsan M. Naduvil Valappil, MD	Dr. Naduvil Valappil has nothing to disclose.
Ana Sofia Morgadinho, MD	No disclosure on file
Pablo Davila Gonzalez	No disclosure on file
Solange Maria Das Gr Camargo, MD	No disclosure on file
Galyna Pushchinska, MD	No disclosure on file
Zeshaun Khawaja, MD	No disclosure on file
Mario Emilio Dourado Junior, Jr.	No disclosure on file
Danny R. Rose, Jr., MD	No disclosure on file
Jafar Kafaie, MD, PhD, FAAN	Dr. Kafaie has nothing to disclose.
Matthew E. Ehrlich, MD	No disclosure on file
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Serge Belinga, MD	No disclosure on file
Babak Rezaei, MD	No disclosure on file
Ho-Yann Jong, MD	No disclosure on file
Duy Le, MD	No disclosure on file
Lauren Schaff, MD, FAAN	Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG, plc. The institution of Dr. Schaff has received research support from BTG, plc. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Ono.
Derek C. Huang, MD	No disclosure on file
Robert W. Regenhardt, MD, PhD	Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Kannan M. Narayana, MD	No disclosure on file
Robert W. Charlson, MD	Dr. Charlson has nothing to disclose.
Rachel M. Donaldson, DO	No disclosure on file
Claire A. Sheldon, MD, PhD	No disclosure on file
Raul Carrera, Sr., MD	No disclosure on file
Jimei Li	No disclosure on file
Chih-Wei Tang, MD	No disclosure on file
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Nicholas A. Morris, MD, FAAN	The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from ��ɫ��. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to AAN interests or activities.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Yahia Z. Imam, MD, FAAN	Dr. Imam has nothing to disclose.
Maria Ernestina Moreira Santos, MD	Maria Ernestina Moreira Santos, MD has nothing to disclose.
Alejandra Calderon, MD	No disclosure on file
Adrian Holden, MD	No disclosure on file
Oscar Martinez, MD	No disclosure on file
Jonathan Ciron, MD	Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Arianna Sartori, MD	No disclosure on file
Fradique V. Moreira	No disclosure on file
Doug Bennion	No disclosure on file
Kristin D. King, MD	No disclosure on file
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Ling Zhang, MD	No disclosure on file
JESSIE K. GREWAL, MD	No disclosure on file
Rouzbeh Fateh, MD	No disclosure on file
Pruthu P. Patel, MD	No disclosure on file
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Matthew B. Freeman, MD	No disclosure on file
Noureldin Abdelhamid, MD	Dr. Abdelhamid has nothing to disclose.
Muhammad Masud, MD	No disclosure on file
Ayman A. Al-Salaimeh, MD	Dr. Al-Salaimeh has nothing to disclose.
Olga R. Thon, MD	Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Thon has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon.
Deepak Kalra, MD, PhD, MPH	Dr. Kalra has nothing to disclose.
Jami H. Johnsen, MD	No disclosure on file
Adam D. Wallace, MD	Dr. Wallace has nothing to disclose.
Abdullah Al Sawaf, MD	Dr. Al Sawaf has nothing to disclose.
Annie S. Daniel, MBBS	Dr. Daniel has nothing to disclose.
Ahmad S. Ghasan, MD	Dr. Ghasan has nothing to disclose.
Hoi Ki, Kate Lui, MD	Dr. Lui has nothing to disclose.
Shareena A. Rahman, MD	Dr. Rahman has nothing to disclose.
Rafael P. Dias-Carneiro, MD	The institution of Dr. Dias-Carneiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. The institution of Dr. Dias-Carneiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Dias-Carneiro has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Astra Zeneca. The institution of Dr. Dias-Carneiro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Dias-Carneiro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Yasushi Suzuki, MD, PhD	Yasushi Suzuki, MD, PhD has nothing to disclose.
Hardeep K. Chohan	No disclosure on file
Akihiro Kubota, MD	No disclosure on file
David Brassat, MD, PhD	No disclosure on file
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Adeniyi A. Borire, MD	Dr. Borire has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Suraj Rajan, MD	No disclosure on file
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
Syed W. Abbas, MD	No disclosure on file
Minsoo Kim, MD	No disclosure on file
Cynthia E. Armand, MD, FAAN	Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CE Interactive. Dr. Armand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Julie G. Shulman, MD	Dr. Shulman has received research support from the BU Spivack Neuroscience Pilot Award.
Benjamin J. Saunders, MD	No disclosure on file
Elizabeth A. Strong, MD	No disclosure on file
Kanika Arora, MD	No disclosure on file
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Jillian Chan, MD	No disclosure on file
Lucido L. Ponce Mejia, MD	No disclosure on file
Divya B. Mella, MD	No disclosure on file
Jan A. Martin, MD	Dr. Martin has nothing to disclose.
Kasra Khatibi, MD	No disclosure on file
Varun Shandal, MD	Dr. Shandal has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for The Killino Firm, P.C..
Nuala McNicholas, MBBS	Dr. McNicholas has nothing to disclose.
Awss Zidan, MD	An immediate family member of Dr. Zidan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ruham Nasany MD.
Mahmoud A. AbdelRazek, MD	Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. AbdelRazek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Imama A. Naqvi, MD, MS	Dr. Naqvi has nothing to disclose.
Sumul Y. Modi, MD	No disclosure on file
Abiodun H. Bello, MD	No disclosure on file
Alexandra C. Simpson, MD	Dr. Simpson has received research support from National MS Society.
Sushrut Jangi, MD	No disclosure on file
Athari K. Salmeen, MD	No disclosure on file
Poorvi P. Dalal, DO	No disclosure on file
Salman Farooq, MD	No disclosure on file
Khadija Irshad, MD	No disclosure on file
Asha V. Shah	No disclosure on file
Yongbo Zhang, MD, PhD	No disclosure on file
Tetsuya Akaishi	Mr. Akaishi has nothing to disclose.
Mosunmola Oyawusi, MD	Dr. Oyawusi has nothing to disclose.
Lindsay Boven	No disclosure on file
Luis F. Tornes, MD	Dr. Tornes has nothing to disclose.
Damiano M. Rovituso	No disclosure on file
Jacqueline Sanchez	No disclosure on file
Priya Narwal, MD	Dr. Narwal has nothing to disclose.
Nicodemus E. Oey	No disclosure on file
Mukesh K. Sriwastva	No disclosure on file
Yoojin Lee, MD	No disclosure on file
Sara H. Duffus	No disclosure on file
Jessica Chorostecki	No disclosure on file
Amanda D. Tomlinson	No disclosure on file
Hayet Salhi	No disclosure on file
Farida Gorram	No disclosure on file
Bianca A. Ulloa	No disclosure on file
Richard Hickman	No disclosure on file
Alissa Gutnikova	No disclosure on file
Elliott Ridgeon	No disclosure on file
Juan Carrizales-Rodriguez, Sr.	No disclosure on file
Felix Gervits	No disclosure on file
Jill Settle	No disclosure on file
Aaron Rothstein, MD	Dr. Rothstein has received personal compensation in the range of $500-$4,999 for serving as a Writer with National Affairs. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving as a Writer with Public Discourse.
Karen Nunley	No disclosure on file
Hemant Tiwari	No disclosure on file
Vasu Saini, MD	Dr. Saini has nothing to disclose.
Kevin Messacar, MD	No disclosure on file
Monica K. Gentchev	No disclosure on file
Muhammed Gunduz, MD	Dr. Gunduz has nothing to disclose.
Dale L. Davis	No disclosure on file
Naveen George, DO	Dr. George has nothing to disclose.
Ana Arenivas, PhD	No disclosure on file
Beatrice Pignolet	Beatrice Pignolet has nothing to disclose.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Dan S. Buch	No disclosure on file
William B. Feldman	No disclosure on file
Valeria Ramaglia	No disclosure on file
JS Charleston	No disclosure on file
Joanne Fielding	No disclosure on file
Kristin Salottolo, MPH	Ms. Salottolo has nothing to disclose.
Alessandra De Paula Alves Sousa	No disclosure on file
Danielle Blemur	No disclosure on file
Michelle Whaley	No disclosure on file
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Andrew Zeft	No disclosure on file
Rodrigo Hasbun	Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.
Langan Ruth-Anne	No disclosure on file
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Fatima Pantiu	No disclosure on file
Brandon Francis, MD	Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Kelsey McDermott	No disclosure on file
Levent Ocek	LEVENT OCEK, 4284 has nothing to disclose.
BEDILE IREM TIFTIKCIOGLU	No disclosure on file
Roberto Santangelo	No disclosure on file
Margaret Kasschau	No disclosure on file
Breanna Caruso	No disclosure on file
Rodolphe Nenert	Rodolphe Nenert has nothing to disclose.
Pak Ho Au	No disclosure on file
Ruben Carrasco Torres	No disclosure on file
Heidemarie Lex, PhD	No disclosure on file
Santina Cutrupi	No disclosure on file
Devanshi Dharaiya, MD	No disclosure on file
Daniel Golan, MD	No disclosure on file
Sana Sharrack	No disclosure on file
Ela M. Akay	No disclosure on file
Joseph C. Griffis	No disclosure on file
Daniel Schonhaut	No disclosure on file
Ian Stewart	No disclosure on file
Sheridan Reed	No disclosure on file
Marlen Lucero	No disclosure on file
Millad J. Sobhanian	No disclosure on file
Jon Yankey	No disclosure on file
Izukanje Sikazwe	No disclosure on file
ABDULAZIZ M. ALQAHTANI, Jr.	No disclosure on file
KHALID M. ASIRI, Jr.	No disclosure on file
Hassan A. Alamri	No disclosure on file
Ali M. Alqahtani	No disclosure on file
Nawaf A. Alqahtani	No disclosure on file
Karin Kleinsteuber, MD	No disclosure on file
Osman Sezerman	No disclosure on file
Eda Turanli	The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .
Jean Levi Ribeiro De Paiva	No disclosure on file
Shihui Xing, MD, PhD	No disclosure on file
Dennis Parker Jr.	No disclosure on file
Carolyn Fredericks, MD	The institution of Dr. Fredericks has received research support from Alzheimer's Association. The institution of Dr. Fredericks has received research support from National Institute on Aging.
Ayman Alboudi, MD	Dr. Alboudi has nothing to disclose.
Yohannes W. Woldeamanuel, MD	Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Research Square. The institution of Dr. Woldeamanuel has received research support from NINDS. Dr. Woldeamanuel has a non-compensated relationship as a Chief Medical Officer, Co-Founder with Ex-Amplify Therapeutics that is relevant to AAN interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Adjunct Faculty with Arizona State University that is relevant to AAN interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Founder & Consultant with Advanced Clinical & Research Center that is relevant to AAN interests or activities.
Dana R. Jorgensen	No disclosure on file
Kathryn A. Giles, MD	No disclosure on file
Chon-Haw Tsai, MD, PhD	No disclosure on file
Jennifer Bickel, MD, FAAN	Dr. Bickel has received personal compensation in the range of $10,000-$49,999 for serving as a faculty with American College of Heathcare Executives. Dr. Bickel has received personal compensation in the range of $5,000-$9,999 for serving as a Burnout in Oncology Advisory Participant with EMD Serono. Dr. Bickel has a non-compensated relationship as a Editorial Advisory Board with Neurology Today that is relevant to AAN interests or activities. Dr. Bickel has a non-compensated relationship as a Subcommittee member with American Headache Society that is relevant to AAN interests or activities. Dr. Bickel has a non-compensated relationship as a Collaborative member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Bickel has a non-compensated relationship as a Committee Member with Florida Medical Association that is relevant to AAN interests or activities. Dr. Bickel has a non-compensated relationship as a Board Director with Collaborative for Health and Renewal in Medicine (CHARM) that is relevant to AAN interests or activities. Dr. Bickel has a non-compensated relationship as a workgroup member with Greater Houston Partnerships - Project Metis that is relevant to AAN interests or activities.
Joerg Windsheimer, MD	No disclosure on file
Ai-Lan Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Nguyen has received research support from MS Research Australia. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as a recipient of conference travel support with Roche.
Claudia Prada	No disclosure on file
Nicholas J. Everage	No disclosure on file
Tobias Derfuss	An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Roche. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Sharp Dome. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has stock in Novartis. An immediate family member of Tobias Derfuss has stock in Roche. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen. The institution of Tobias Derfuss has received research support from Alexion.
Cameron Brennan	Cameron Brennan has nothing to disclose.
Brianna Brun	Dr. Brun has received research support from National Institute of Neurological Disorders and Stroke.
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Thomas Neylan	The institution of Thomas Neylan has received research support from National Institutes of Aging.
Greg Mytyk	No disclosure on file
Jie Ting	No disclosure on file
Sara L. Wiley	No disclosure on file
RJ Wirth, PhD	RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.

��ɫ����

��ɫ����

��ɫ��

��ɫ��